Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	microfilament motor activity	MYH1 MYH2 MYH4 MYH7B MYO1B	1.75e-06	38	107	5	GO:0000146
GeneOntologyMolecularFunction	medium-chain fatty acid omega-hydroxylase activity	CYP4A11 CYP4A22	2.84e-05	2	107	2	GO:0140981
GeneOntologyMolecularFunction	16-hydroxypalmitate dehydrogenase activity	CYP4A11 CYP4A22	2.84e-05	2	107	2	GO:0103002
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH1 MYH2 MYH4 MYH7B MYO1B KIF13A	4.17e-05	118	107	6	GO:0003774
GeneOntologyMolecularFunction	monoamine oxidase activity	MAOA MAOB	8.50e-05	3	107	2	GO:0097621
GeneOntologyMolecularFunction	aliphatic amine oxidase activity	MAOA MAOB	1.69e-04	4	107	2	GO:0052595
GeneOntologyMolecularFunction	leukotriene-B4 20-monooxygenase activity	CYP4A11 CYP4A22	5.87e-04	7	107	2	GO:0050051
GeneOntologyMolecularFunction	alkane 1-monooxygenase activity	CYP4A11 CYP4A22	5.87e-04	7	107	2	GO:0018685
GeneOntologyMolecularFunction	primary methylamine oxidase activity	MAOA MAOB	9.99e-04	9	107	2	GO:0008131
GeneOntologyMolecularFunction	arachidonate omega-hydroxylase activity	CYP4A11 CYP4A22	1.24e-03	10	107	2	GO:0052869
GeneOntologyMolecularFunction	fatty acid omega-hydroxylase activity	CYP4A11 CYP4A22	1.24e-03	10	107	2	GO:0120250
GeneOntologyMolecularFunction	long-chain fatty acid omega-hydroxylase activity	CYP4A11 CYP4A22	1.24e-03	10	107	2	GO:0102033
GeneOntologyMolecularFunction	unmethylated CpG binding	CXXC1 KDM2B	1.24e-03	10	107	2	GO:0045322
GeneOntologyMolecularFunction	actin filament binding	MYH1 MYH2 MYH4 MYH7B SYNE1 MYO1B	1.41e-03	227	107	6	GO:0051015
GeneOntologyMolecularFunction	calmodulin binding	MYH1 MYH2 MYH4 MYO1B RIT1 PLCB3	1.50e-03	230	107	6	GO:0005516
GeneOntologyBiologicalProcess	transcription by RNA polymerase III	BDP1 DHX36 POLR1C BAZ1B SF3B1	1.89e-05	63	107	5	GO:0006383
GeneOntologyBiologicalProcess	phenylethylamine metabolic process	MAOA MAOB	2.67e-05	2	107	2	GO:0042443
GeneOntologyBiologicalProcess	transcription by RNA polymerase I	POLR1C BAZ1B CREBBP SF3B1 POLR1E	5.68e-05	79	107	5	GO:0006360
GeneOntologyBiologicalProcess	lauric acid metabolic process	CYP4A11 CYP4A22	7.97e-05	3	107	2	GO:0048252
GeneOntologyCellularComponent	myosin filament	MYH1 MYH2 MYH4 MYH7B	7.28e-06	25	106	4	GO:0032982
GeneOntologyCellularComponent	myosin II complex	MYH1 MYH2 MYH4 MYH7B	1.16e-05	28	106	4	GO:0016460
GeneOntologyCellularComponent	myosin complex	MYH1 MYH2 MYH4 MYH7B MYO1B	1.23e-05	59	106	5	GO:0016459
GeneOntologyCellularComponent	nuclear body	MYC DHX36 E2F7 PRPF6 ZC3H18 THOC2 TRIM27 CREBBP CXXC1 ARRB1 SF3B1 EIF4ENIF1 EPC1 NHS THRAP3	4.99e-05	903	106	15	GO:0016604
GeneOntologyCellularComponent	muscle myosin complex	MYH1 MYH2 MYH4	6.76e-05	16	106	3	GO:0005859
GeneOntologyCellularComponent	piccolo histone acetyltransferase complex	EPC2 EPC1	1.52e-04	4	106	2	GO:0032777
GeneOntologyCellularComponent	nuclear speck	DHX36 E2F7 PRPF6 ZC3H18 THOC2 CXXC1 SF3B1 EIF4ENIF1 THRAP3	3.48e-04	431	106	9	GO:0016607
GeneOntologyCellularComponent	B-WICH complex	BAZ1B SF3B1	6.99e-04	8	106	2	GO:0110016
Domain	Myosin_N	MYH1 MYH2 MYH4 MYH7B	1.65e-06	15	113	4	PF02736
Domain	Myosin_N	MYH1 MYH2 MYH4 MYH7B	1.65e-06	15	113	4	IPR004009
Domain	Myosin_head_motor_dom	MYH1 MYH2 MYH4 MYH7B MYO1B	3.17e-06	38	113	5	IPR001609
Domain	MYOSIN_MOTOR	MYH1 MYH2 MYH4 MYH7B MYO1B	3.17e-06	38	113	5	PS51456
Domain	Myosin_head	MYH1 MYH2 MYH4 MYH7B MYO1B	3.17e-06	38	113	5	PF00063
Domain	MYSc	MYH1 MYH2 MYH4 MYH7B MYO1B	3.17e-06	38	113	5	SM00242
Domain	Myosin_tail_1	MYH1 MYH2 MYH4 MYH7B	3.64e-06	18	113	4	PF01576
Domain	Myosin_tail	MYH1 MYH2 MYH4 MYH7B	3.64e-06	18	113	4	IPR002928
Domain	Liprin	PPFIA4 PPFIA2 PPFIA1	4.26e-06	6	113	3	IPR029515
Domain	Myosin-like_IQ_dom	MYH1 MYH2 MYH4 MYH7B	4.59e-06	19	113	4	IPR027401
Domain	-	MYH1 MYH2 MYH4 MYH7B	4.59e-06	19	113	4	4.10.270.10
Domain	IQ	MYH1 MYH2 MYH4 MYH7B MYO1B CEP131	9.63e-06	81	113	6	SM00015
Domain	IQ_motif_EF-hand-BS	MYH1 MYH2 MYH4 MYH7B MYO1B CEP131	1.77e-05	90	113	6	IPR000048
Domain	IQ	MYH1 MYH2 MYH4 MYH7B MYO1B CEP131	2.13e-05	93	113	6	PS50096
Domain	Enhancer_polycomb	EPC2 EPC1	3.63e-05	2	113	2	IPR024943
Domain	Enhancer_polycomb_C	EPC2 EPC1	3.63e-05	2	113	2	IPR009607
Domain	E_Pc_C	EPC2 EPC1	3.63e-05	2	113	2	PF06752
Domain	IQ	MYH1 MYH2 MYH4 MYO1B CEP131	7.03e-05	71	113	5	PF00612
Domain	NPIP	NPIPB2 NPIPB8 NPIPB6	7.48e-05	14	113	3	IPR009443
Domain	Flavin_amine_oxidase	MAOA MAOB	1.08e-04	3	113	2	IPR001613
Domain	PLC-beta_C	PLCB2 PLCB3	1.08e-04	3	113	2	IPR014815
Domain	PLC-beta_C	PLCB2 PLCB3	1.08e-04	3	113	2	PF08703
Domain	PLC-beta	PLCB2 PLCB3	2.16e-04	4	113	2	IPR016280
Domain	SAM_1	PPFIA4 PPFIA2 PPFIA1 UBP1	7.68e-04	68	113	4	PF00536
Domain	EPL1	EPC2 EPC1	9.92e-04	8	113	2	PF10513
Domain	Enhancer_polycomb-like_N	EPC2 EPC1	9.92e-04	8	113	2	IPR019542
Domain	Amino_oxidase	MAOA MAOB	1.58e-03	10	113	2	IPR002937
Domain	Amino_oxidase	MAOA MAOB	1.58e-03	10	113	2	PF01593
Domain	-	RGPD3 GOLGA4	1.58e-03	10	113	2	1.10.220.60
Domain	Znf_CXXC	CXXC1 KDM2B	1.93e-03	11	113	2	IPR002857
Domain	ZF_CXXC	CXXC1 KDM2B	1.93e-03	11	113	2	PS51058
Domain	Grip	RGPD3 GOLGA4	1.93e-03	11	113	2	SM00755
Domain	zf-CXXC	CXXC1 KDM2B	1.93e-03	11	113	2	PF02008
Domain	GRIP	RGPD3 GOLGA4	1.93e-03	11	113	2	PF01465
Domain	SAM_2	PPFIA4 PPFIA2 PPFIA1	2.23e-03	43	113	3	PF07647
Domain	GRIP_dom	RGPD3 GOLGA4	2.30e-03	12	113	2	IPR000237
Domain	GRIP	RGPD3 GOLGA4	2.30e-03	12	113	2	PS50913
Domain	SAM	PPFIA4 PPFIA2 PPFIA1 UBP1	2.86e-03	97	113	4	IPR001660
Domain	PLipase_C_Pinositol-sp_Y	PLCB2 PLCB3	3.62e-03	15	113	2	IPR001711
Domain	EF-hand_like	PLCB2 PLCB3	3.62e-03	15	113	2	PF09279
Domain	PIPLC_Y_DOMAIN	PLCB2 PLCB3	3.62e-03	15	113	2	PS50008
Domain	PI-PLC_fam	PLCB2 PLCB3	3.62e-03	15	113	2	IPR001192
Domain	PLC_EF-hand-like	PLCB2 PLCB3	3.62e-03	15	113	2	IPR015359
Domain	PI-PLC-Y	PLCB2 PLCB3	3.62e-03	15	113	2	PF00387
Domain	PLCYc	PLCB2 PLCB3	3.62e-03	15	113	2	SM00149
Domain	-	PPFIA4 PPFIA2 PPFIA1 UBP1	3.93e-03	106	113	4	1.10.150.50
Domain	PH_dom-like	PDPK1 MYO1B STAP1 RGPD3 OSBPL10 PLCB2 PLCB3 GULP1	4.37e-03	426	113	8	IPR011993
Domain	PI-PLC-X	PLCB2 PLCB3	5.21e-03	18	113	2	PF00388
Domain	PLCXc	PLCB2 PLCB3	5.21e-03	18	113	2	SM00148
Domain	SAM/pointed	PPFIA4 PPFIA2 PPFIA1 UBP1	5.58e-03	117	113	4	IPR013761
Domain	Znf_ZZ	CREBBP TADA2A	5.80e-03	19	113	2	IPR000433
Domain	PIPLC_X_DOMAIN	PLCB2 PLCB3	5.80e-03	19	113	2	PS50007
Domain	PLipase_C_PInositol-sp_X_dom	PLCB2 PLCB3	5.80e-03	19	113	2	IPR000909
Domain	ZnF_ZZ	CREBBP TADA2A	5.80e-03	19	113	2	SM00291
Pathway	REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE	MAOA PPFIA4 PPFIA2 PPFIA1	2.38e-06	18	77	4	M13015
Pathway	REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE	MAOA PPFIA4 PPFIA2 PPFIA1	2.38e-06	18	77	4	MM14703
Pathway	PID_IL8_CXCR1_PATHWAY	PDPK1 ARRB1 PLCB2 PLCB3	1.53e-05	28	77	4	M252
Pathway	REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION	POLR1C BAZ1B SF3B1 POLR1E	2.02e-05	30	77	4	MM15173
Pathway	PID_IL8_CXCR2_PATHWAY	PDPK1 ARRB1 PLCB2 PLCB3	3.37e-05	34	77	4	M210
Pathway	REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION	POLR1C BAZ1B CXXC1 SF3B1 POLR1E TADA2A	9.76e-05	136	77	6	MM14848
Pathway	REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE	PPFIA4 PPFIA2 PPFIA1	1.01e-04	17	77	3	M93
Pathway	REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE	PPFIA4 PPFIA2 PPFIA1	1.01e-04	17	77	3	MM14907
Pathway	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	MAOA PPFIA4 PDPK1 PPFIA2 PPFIA1 ADCY7 PLCB2 PLCB3	1.10e-04	270	77	8	M15514
Pathway	REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE	PPFIA4 PPFIA2 PPFIA1	1.21e-04	18	77	3	MM14702
Pathway	REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE	PPFIA4 PPFIA2 PPFIA1	1.21e-04	18	77	3	M27043
Pathway	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	MAOA PPFIA4 PPFIA2 PPFIA1 ADCY7 PLCB2 PLCB3	1.51e-04	211	77	7	MM14502
Pathway	REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES	PPFIA4 PPFIA2 PPFIA1	1.67e-04	20	77	3	M27290
Pathway	REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES	PPFIA4 PPFIA2 PPFIA1	1.67e-04	20	77	3	MM14991
Pathway	REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE	MAOA PPFIA4 PPFIA2 PPFIA1	1.69e-04	51	77	4	M4281
Pathway	REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE	MAOA PPFIA4 PPFIA2 PPFIA1	1.69e-04	51	77	4	MM14499
Pathway	REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE	PPFIA4 PPFIA2 PPFIA1	2.57e-04	23	77	3	MM14852
Pathway	REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE	PPFIA4 PPFIA2 PPFIA1	2.57e-04	23	77	3	M12627
Pathway	KEGG_MEDICUS_REFERENCE_SEROTONIN_METABOLISM	MAOA MAOB	2.91e-04	5	77	2	M47902
Pathway	REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE	PPFIA4 PPFIA2 PPFIA1	2.92e-04	24	77	3	MM14834
Pathway	REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE	PPFIA4 PPFIA2 PPFIA1	2.92e-04	24	77	3	M630
Pathway	REACTOME_NEURONAL_SYSTEM	MAOA PPFIA4 PDPK1 PPFIA2 PPFIA1 ADCY7 PLCB2 PLCB3 GJA10	3.90e-04	411	77	9	M735
Pathway	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	CYP4A11 ADCY7 CYP4A22 PLCB2 PLCB3	4.10e-04	115	77	5	M9387
Pathway	KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY	PLCB2 PLCB3	4.36e-04	6	77	2	M47548
Pathway	REACTOME_NEURONAL_SYSTEM	MAOA PPFIA4 PPFIA2 PPFIA1 ADCY7 PLCB2 PLCB3 GJA10	4.73e-04	335	77	8	MM14503
Pathway	KEGG_PPAR_SIGNALING_PATHWAY	CYP4A11 PDPK1 SCD5 CYP4A22	5.44e-04	69	77	4	M13088
Pathway	WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS	ARRB1 PLCB2 PLCB3	5.72e-04	30	77	3	M42578
Pathway	KEGG_VIRAL_MYOCARDITIS	MYH1 MYH2 MYH4 MYH7B	5.74e-04	70	77	4	M12294
Pathway	KEGG_MEDICUS_REFERENCE_CASR_PTH_SIGNALING_PATHWAY	PLCB2 PLCB3	6.08e-04	7	77	2	M47505
Pathway	WP_PPAR_SIGNALING_PATHWAY	CYP4A11 PDPK1 SCD5 CYP4A22	6.73e-04	73	77	4	MM15995
Pathway	REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING	PDPK1 PLCB2 PLCB3	6.93e-04	32	77	3	M14309
Pathway	REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING	PDPK1 PLCB2 PLCB3	7.60e-04	33	77	3	MM15027
Pathway	REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION	PLCB2 PLCB3	8.07e-04	8	77	2	MM15032
Pathway	REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION	MYC CREBBP	8.07e-04	8	77	2	M48024
Pathway	REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION	PLCB2 PLCB3	8.07e-04	8	77	2	M27356
Pathway	REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION	PLCB2 PLCB3	8.07e-04	8	77	2	MM15100
Pathway	WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY	CYP4A11 CYP4A22	1.03e-03	9	77	2	M39819
Pathway	REACTOME_GENE_EXPRESSION_TRANSCRIPTION	MYC BDP1 PDPK1 POLR1C E2F7 BAZ1B THOC2 CXXC1 SF3B1 POLR1E RGPD3 EPC1 TPX2 TADA2A	1.15e-03	1022	77	14	MM15436
Pathway	REACTOME_G_PROTEIN_MEDIATED_EVENTS	ADCY7 PLCB2 PLCB3	1.24e-03	39	77	3	MM14496
Pathway	WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY	ARRB1 PLCB2 PLCB3	1.24e-03	39	77	3	M39905
Pathway	KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY	PLCB2 PLCB3	1.29e-03	10	77	2	M47644
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY	PLCB2 PLCB3	1.29e-03	10	77	2	M47661
Pathway	REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION	PLCB2 PLCB3	1.29e-03	10	77	2	M1825
Pathway	KEGG_WNT_SIGNALING_PATHWAY	MYC CREBBP VANGL1 PLCB2 PLCB3	1.40e-03	151	77	5	M19428
Pathway	REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION	POLR1C BAZ1B SF3B1 POLR1E	1.47e-03	90	77	4	M29668
Pathway	REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION	PLCB2 PLCB3	1.57e-03	11	77	2	M27317
Pathway	REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION	PLCB2 PLCB3	1.57e-03	11	77	2	MM15035
Pathway	KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY	PLCB2 PLCB3	1.57e-03	11	77	2	M47637
Pathway	REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE	CYP4A11 CYP4A22	1.57e-03	11	77	2	MM14863
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY	PLCB2 PLCB3	1.57e-03	11	77	2	M49033
Pathway	PID_THROMBIN_PAR1_PATHWAY	ARRB1 PLCB2 PLCB3	1.65e-03	43	77	3	M238
Pathway	REACTOME_EICOSANOIDS	CYP4A11 CYP4A22	1.88e-03	12	77	2	M27129
Pathway	REACTOME_MISCELLANEOUS_SUBSTRATES	CYP4A11 CYP4A22	1.88e-03	12	77	2	M27128
Pathway	KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY	PLCB2 PLCB3	1.88e-03	12	77	2	M47649
Pathway	KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY	PLCB2 PLCB3	1.88e-03	12	77	2	M47628
Pathway	REACTOME_EICOSANOIDS	CYP4A11 CYP4A22	1.88e-03	12	77	2	MM14845
Pathway	WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY	FIG4 PLCB2 PLCB3	2.01e-03	46	77	3	M48317
Pathway	PID_CXCR4_PATHWAY	PDPK1 SSH1 PLCB2 PLCB3	2.17e-03	100	77	4	M124
Pathway	KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY	PLCB2 PLCB3	2.21e-03	13	77	2	M47656
Pathway	WP_DOPAMINE_METABOLISM	MAOA MAOB	2.21e-03	13	77	2	M39622
Pathway	KEGG_MELANOGENESIS	CREBBP ADCY7 PLCB2 PLCB3	2.25e-03	101	77	4	M7761
Pathway	REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS	MAOA MAOB CYP4A11 CYP4A22	2.50e-03	104	77	4	M738
Pathway	WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES	CYP4A11 CYP4A22	2.57e-03	14	77	2	MM15842
Pathway	REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS	MAOA MAOB CYP4A11 CYP4A22	2.59e-03	105	77	4	MM14842
Pathway	REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION	POLR1C BAZ1B SF3B1 POLR1E	2.59e-03	105	77	4	M27425
Pathway	REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION	POLR1C BAZ1B CXXC1 SF3B1 POLR1E TADA2A	2.63e-03	254	77	6	M27131
Pathway	WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME	MYC BAZ1B GTF2I SF3B1	2.68e-03	106	77	4	M40052
Pathway	PID_KIT_PATHWAY	PDPK1 CREBBP STAP1	2.86e-03	52	77	3	M231
Pathway	WP_GPR40_PATHWAY	PLCB2 PLCB3	2.95e-03	15	77	2	M39526
Pathway	REACTOME_FATTY_ACIDS	CYP4A11 CYP4A22	2.95e-03	15	77	2	M27126
Pathway	WP_RUBINSTEINTAYBI_SYNDROME_1	CREBBP POLR1E	2.95e-03	15	77	2	M48323
Pathway	WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE	MAOA MAOB	2.95e-03	15	77	2	M45537
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	RPL21 MYC EPC2 KRT18 POLR1C RPS13 BAZ1B RPS18 PRPF6 ZC3H18 THOC2 TRIM27 CXXC1 NKRF GTF2I SF3B1 POLR1E UBP1 NOM1 ZNF644 RGPD3 EPC1 TPX2 KDM2B UTP20 TADA2A SPEN THRAP3	1.45e-15	1294	115	28	30804502
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	RPL21 MYC RALGAPA1 DHX36 KRT18 POLR1C RPS13 BAZ1B MYO1B RPS18 MCM6 PRPF6 THOC2 NKRF GTF2I NOP14 SF3B1 POLR1E TPX2 UTP20 CDK11B THRAP3	1.41e-12	989	115	22	36424410
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	RPL21 DHX36 KRT18 POLR1C RPS13 BAZ1B DNAJC21 MYO1B RPS18 PRPF6 ZC3H18 THOC2 TRIM27 NKRF CEP55 GTF2I NOP14 SF3B1 POLR1E NOM1 TPX2 UTP20 SPEN THRAP3	2.99e-12	1257	115	24	36526897
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	RPL21 DHX36 KRT18 POLR1C RPS13 BAZ1B MYO1B RPS18 PRPF6 ZC3H18 SYBU THOC2 NKRF GTF2I NOP14 UBP1 NOM1 TPX2 UTP20 THRAP3	5.72e-12	847	115	20	35850772
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	RPL21 KRT18 RPS13 BAZ1B MYO1B RPS18 MCM6 PRPF6 ZC3H18 NKRF GTF2I NOP14 SF3B1 NOM1 CDK11B SPEN THRAP3	1.77e-11	605	115	17	28977666
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	SYNE1 PPFIA1 MYO1B THOC2 TRIM27 NKRF GTF2I SF3B1 NOM1 TPX2 KIF13A THRAP3	2.17e-11	234	115	12	36243803
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	MCM6 STMN1 THOC2 WNK1 STAP1 GTF2I SF3B1 EPC1 TPX2 NHS CEP131 CDK11B KIF13A SPEN THRAP3	1.31e-10	503	115	15	16964243
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RPL21 MYH1 MYH2 MYH4 GTPBP6 KRT18 MYH7B PPFIA4 SYNE1 PPFIA2 PPFIA1 DNAJC21 MYO1B PRPF6 CXXC1 ARRB1 NOP14 SF3B1 RGPD3 CEP295 SPEN THRAP3 BAHCC1	3.17e-10	1442	115	23	35575683
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	RPL21 KRT18 SYNE1 RPS13 DNAJC21 MYO1B RPS18 MCM6 PRPF6 THOC2 NKRF FAM111B GTF2I SF3B1 NOM1 TPX2 UTP20 CDK11B THRAP3	3.31e-10	949	115	19	36574265
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	RPL21 MYC DHX36 KRT18 POLR1C RPS13 ELP1 BAZ1B MYO1B RPS18 MCM6 PRPF6 CREBBP CXXC1 NKRF GTF2I NOP14 SF3B1 POLR1E UTP20 THRAP3 GOLGA4	5.71e-10	1353	115	22	29467282
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	BDP1 GRIPAP1 E2F7 ELP1 BAZ1B MYO1B ZC3H18 WNK1 CREBBP FAM111B ZNF644 KDM2B CEP131 CDK11B SPEN	1.12e-09	588	115	15	38580884
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	RPL21 KRT18 SYNE1 RPS13 ELP1 BAZ1B MYO1B RPS18 MCM6 PRPF6 THOC2 NKRF CEP350 SF3B1 VANGL1 UTP20 CEP131 SPEN THRAP3	1.16e-09	1024	115	19	24711643
Pubmed	Human transcription factor protein interaction networks.	MYC DHX36 EPC2 ZNF536 RPS13 BAZ1B MYO1B ZC3H18 STMN1 CREBBP CXXC1 NKRF GTF2I NOP14 EIF4ENIF1 ZNF644 EPC1 TPX2 KDM2B CEP131 TADA2A SPEN	1.57e-09	1429	115	22	35140242
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	RPL21 MYC EPC2 ZNF536 MCM6 TRIM27 CREBBP NKRF NOP14 SF3B1 UBP1 ZNF644 EPC1 TPX2 UTP20 SPEN THRAP3	3.56e-09	857	115	17	25609649
Pubmed	GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system.	RPL21 RPS13 E2F7 ELP1 MYO1B RPS18 NKRF SF3B1 NOM1 THRAP3	3.65e-09	221	115	10	29991511
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	GTPBP6 SYNE1 PPFIA1 POLR1C BAZ1B DNAJC21 TRIM27 NKRF CEP55 ARRB1 NOP14 EIF4ENIF1 POLR1E VANGL1 UBP1 NOM1 RGPD3 TPX2 KDM2B UTP20 CEP131 SPEN	3.67e-09	1497	115	22	31527615
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	RPL21 DHX36 ELP1 BAZ1B MYO1B MCM6 PRPF6 ZC3H18 THOC2 NKRF GTF2I NOP14 SF3B1 UTP20 SPEN	4.60e-09	653	115	15	22586326
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	PDPK1 BAZ1B ZC3H18 THOC2 GTF2I SF3B1 SSH1 ZNF644 TPX2 KDM2B UTP20 PLCB3 CDK11B SPEN THRAP3 GOLGA4	6.01e-09	774	115	16	15302935
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	RPL21 RALGAPA1 SYNE1 PPFIA1 POLR1C RPS13 ELP1 BAZ1B DNAJC21 PRPF6 SCD5 TRIM27 CEP55 NOP14 SF3B1 FAM193A VANGL1 ZNF644 CEP131 SEMA6A GOLGA4	1.74e-08	1487	115	21	33957083
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	RALGAPA1 ZNF536 GRIPAP1 PPFIA1 SCD5 WNK1 CEP350 FAM193A EIF4ENIF1 VANGL1 TPX2 CEP131 CEP295 CDK11B GOLGA4	2.13e-08	733	115	15	34672954
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	RPL21 DHX36 POLR1C RPS13 BAZ1B DNAJC21 RPS18 PRPF6 THOC2 NKRF NOP14 POLR1E NOM1 TPX2 UTP20	3.36e-08	759	115	15	35915203
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	RPL21 KRT18 RPS13 MYO1B RPS18 ZC3H18 TRIM27 CREBBP NKRF TPX2 THRAP3	3.52e-08	361	115	11	30344098
Pubmed	Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation.	MYH1 MYH2 MYH4	3.52e-08	3	115	3	26059207
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	RPL21 DHX36 KRT18 RPS13 RPS18 PRPF6 ZC3H18 NKRF SF3B1 FAM193A EIF4ENIF1 NOM1 UTP20 THRAP3	3.81e-08	655	115	14	35819319
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	BAZ1B ZC3H18 STMN1 THOC2 GTF2I SF3B1 TPX2 CDK11B SPEN THRAP3	3.82e-08	283	115	10	30585729
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	RPL21 DHX36 SYNE1 RPS13 RPS18 ZC3H18 NKRF NOP14 SF3B1 EIF4ENIF1 NOM1 UTP20 CDK11B SPEN THRAP3	7.46e-08	807	115	15	22681889
Pubmed	Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle.	MYH1 MYH2 MYH4	1.41e-07	4	115	3	11029314
Pubmed	Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling.	MYH1 MYH2 MYH4	1.41e-07	4	115	3	18417546
Pubmed	Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity.	MYH1 MYH2 MYH4	1.41e-07	4	115	3	10388558
Pubmed	A human YAC transgene rescues craniofacial and neural tube development in PDGFRalpha knockout mice and uncovers a role for PDGFRalpha in prenatal lung growth.	MYH1 MYH2 MYH4	1.41e-07	4	115	3	11023856
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	RPL21 MYC DHX36 POLR1C RPS13 ELP1 MYO1B RPS18 MCM6 PRPF6 THOC2 TRIM27 NKRF GTF2I SF3B1 POLR1E NOM1 RGPD3	1.69e-07	1257	115	18	37317656
Pubmed	A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance.	MYH1 MYH2 MYH4 MYH7B	2.00e-07	16	115	4	19922871
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	DHX36 BAZ1B PRPF6 ZC3H18 NKRF NOP14 ZNF644 TPX2 SPEN THRAP3	2.16e-07	341	115	10	32971831
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	RPL21 GTPBP6 RPS13 BAZ1B RPS18 ZC3H18 THOC2 ARRB1 GTF2I NOM1 TPX2 ARHGAP45	2.19e-07	533	115	12	30554943
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	RPL21 MYC DHX36 MYH2 MYH4 KRT18 RAB11FIP2 POLR1C E2F7 MYO1B PRPF6 ARRB1 GTF2I SF3B1 POLR1E NOM1 CDK11B THRAP3	2.31e-07	1284	115	18	17353931
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	MYC POLR1C BAZ1B MCM6 PRPF6 ZC3H18 STMN1 THOC2 CREBBP NKRF GTF2I SF3B1 POLR1E TPX2 CDK11B THRAP3	2.44e-07	1014	115	16	32416067
Pubmed	Interaction network of human early embryonic transcription factors.	EPC2 ZNF536 BAZ1B CREBBP ZNF644 EPC1 KDM2B TADA2A SPEN BAHCC1	2.81e-07	351	115	10	38297188
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	RALGAPA1 PPFIA1 RAB11FIP2 ELP1 THOC2 TRIM27 WNK1 FAM193A EIF4ENIF1 CEP131 CEP295	2.94e-07	446	115	11	24255178
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	GRIPAP1 PPFIA1 CEP350 AP4E1 GTF2I SF3B1 VANGL1 NOM1 OSBPL10 CEP131 DEPDC7 SPEN THRAP3 GOLGA4	3.05e-07	777	115	14	35844135
Pubmed	Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro.	MYH1 MYH2 MYH4	3.50e-07	5	115	3	3829126
Pubmed	The mouse and human Liprin-alpha family of scaffolding proteins: genomic organization, expression profiling and regulation by alternative splicing.	PPFIA4 PPFIA2 PPFIA1	3.50e-07	5	115	3	19013515
Pubmed	Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development.	MYH1 MYH2 MYH4	3.50e-07	5	115	3	12919077
Pubmed	Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections.	MYH1 MYH2 MYH4	3.50e-07	5	115	3	30737693
Pubmed	Sequential accumulation of mRNAs encoding different myosin heavy chain isoforms during skeletal muscle development in vivo detected with a recombinant plasmid identified as coding for an adult fast myosin heavy chain from mouse skeletal muscle.	MYH1 MYH2 MYH4	3.50e-07	5	115	3	6196357
Pubmed	Distinct myogenic programs of embryonic and fetal mouse muscle cells: expression of the perinatal myosin heavy chain isoform in vitro.	MYH1 MYH2 MYH4	6.99e-07	6	115	3	1728586
Pubmed	A hypoplastic model of skeletal muscle development displaying reduced foetal myoblast cell numbers, increased oxidative myofibres and improved specific tension capacity.	MYH1 MYH2 MYH4	6.99e-07	6	115	3	20417199
Pubmed	Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved.	MYH1 MYH2 MYH4	6.99e-07	6	115	3	10077619
Pubmed	Analyses of the spatiotemporal expression and subcellular localization of liprin-α proteins.	PPFIA4 PPFIA2 PPFIA1	6.99e-07	6	115	3	21618221
Pubmed	A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre.	MYH1 MYH2 MYH4	6.99e-07	6	115	3	17559643
Pubmed	Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development.	MYH1 MYH2 MYH4	6.99e-07	6	115	3	10588881
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	RPL21 POLR1C RPS13 ELP1 BAZ1B MYO1B RPS18 MCM6 PRPF6 SF3B1 NOM1 THRAP3	7.78e-07	601	115	12	33658012
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MYC EPC2 ZNF536 PPFIA1 BAZ1B ZC3H18 TRIM27 CREBBP NKRF EIF4ENIF1 POLR1E VANGL1 EPC1 CEP295 TADA2A BAHCC1	8.66e-07	1116	115	16	31753913
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	RPL21 DHX36 KRT18 POLR1C RPS13 ELP1 RPS18 MCM6 PRPF6 ZC3H18 WNK1 ARRB1 GTF2I SF3B1 OTUD6B PLCB3 THRAP3 GOLGA4	9.42e-07	1415	115	18	28515276
Pubmed	Interaction between GRIP and liprin-alpha/SYD2 is required for AMPA receptor targeting.	PPFIA4 PPFIA2 PPFIA1	1.22e-06	7	115	3	11931740
Pubmed	A fast Myosin super enhancer dictates muscle fiber phenotype through competitive interactions with Myosin genes.	MYH1 MYH2 MYH4	1.22e-06	7	115	3	35210422
Pubmed	ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism.	MYH1 MYH2 MYH4	1.22e-06	7	115	3	29758057
Pubmed	Diversity in transcriptional start site selection and alternative splicing affects the 5'-UTR of mouse striated muscle myosin transcripts.	MYH1 MYH2 MYH4	1.22e-06	7	115	3	16819597
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ZNF536 PPFIA1 GTF2I FAM193A EIF4ENIF1 ZNF644 RGPD3 KDM2B CEP131 TADA2A	1.37e-06	418	115	10	34709266
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	MYH2 ZNF536 ELP1 CREBBP CEP350 ANKRD36B POLR1E UBP1 KDM2B CEP295 SPEN ARHGAP45	1.45e-06	638	115	12	31182584
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	EPC2 THOC2 WNK1 CREBBP FAM111B CEP55 CEP350 EPC1 TPX2 CEP131 SPEN THRAP3	1.62e-06	645	115	12	25281560
Pubmed	Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.	RPL21 KRT18 POLR1C RPS13 BAZ1B RPS18 PRPF6 THOC2 GTF2I SF3B1 TPX2 THRAP3	1.81e-06	652	115	12	31180492
Pubmed	Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.	RPL21 RALGAPA1 DHX36 MYH1 GRIPAP1 KRT18 RPS13 RPS18 STMN1 SF3B1 CDK11B	1.83e-06	538	115	11	28524877
Pubmed	Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions.	MYC ZNF536 TMEM51 CREBBP SF3B1 SPEN	1.86e-06	110	115	6	37219487
Pubmed	Cell lineage- and expression-based inference of the roles of forkhead box transcription factor Foxc2 in craniofacial development.	MYH1 MYH2 MYH4	1.95e-06	8	115	3	33667029
Pubmed	A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning.	MYH1 MYH2 MYH4	1.95e-06	8	115	3	14667415
Pubmed	Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.	MYH1 MYH2 MYH4	1.95e-06	8	115	3	26993635
Pubmed	Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.	RPS13 BAZ1B RPS18 PRPF6 THOC2 SF3B1 POLR1E UTP20 THRAP3	2.08e-06	340	115	9	29478914
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	BAZ1B STMN1 THOC2 CREBBP NKRF CEP55 GTF2I TPX2 KDM2B SPEN THRAP3	2.23e-06	549	115	11	38280479
Pubmed	Analysis of the Histone H3.1 Interactome: A Suitable Chaperone for the Right Event.	KRT18 E2F7 RPS18 MCM6 GTF2I SF3B1 THRAP3	2.61e-06	182	115	7	26527279
Pubmed	GASP-2 overexpressing mice exhibit a hypermuscular phenotype with contrasting molecular effects compared to GASP-1 transgenics.	MYH1 MYH2 MYH4	2.92e-06	9	115	3	31960486
Pubmed	Interaction between liprin-alpha and GIT1 is required for AMPA receptor targeting.	PPFIA4 PPFIA2 PPFIA1	2.92e-06	9	115	3	12629171
Pubmed	Interaction of the ERC family of RIM-binding proteins with the liprin-alpha family of multidomain proteins.	PPFIA4 PPFIA2 PPFIA1	2.92e-06	9	115	3	12923177
Pubmed	Genome-wide mapping of Sox6 binding sites in skeletal muscle reveals both direct and indirect regulation of muscle terminal differentiation by Sox6.	MYH1 MYH2 MYH4 MYH7B	3.33e-06	31	115	4	21985497
Pubmed	Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics.	SYNE1 PPFIA2 PPFIA1 RPS13 ELP1 MYO1B STMN1 CEP350 GTF2I SF3B1 VANGL1	3.35e-06	573	115	11	28330616
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	KRT18 BAZ1B RPS18 PRPF6 ZC3H18 THOC2 NKRF GTF2I SF3B1 ZNF644 TPX2 CDK11B SPEN THRAP3	3.39e-06	954	115	14	36373674
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	RPL21 DHX36 KRT18 POLR1C RPS13 DNAJC21 MYO1B RPS18 MCM6 PRPF6 THOC2 NKRF SF3B1 KDM2B NHS THRAP3	3.62e-06	1247	115	16	27684187
Pubmed	RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.	RPL21 DHX36 KRT18 RPS13 RPS18 PRPF6 ZC3H18 THOC2 NKRF NOP14 CDK11B THRAP3	4.52e-06	713	115	12	29802200
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	RPL21 DHX36 SYNE1 RPS13 ELP1 BAZ1B MYO1B RPS18 MCM6 PRPF6 THOC2 GTF2I SF3B1 UTP20 SPEN THRAP3 GOLGA4	4.60e-06	1425	115	17	30948266
Pubmed	KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4.	PPFIA1 THOC2 NKRF GTF2I SF3B1 THRAP3	4.90e-06	130	115	6	35545047
Pubmed	A Noncanonical Role of Fructose-1, 6-Bisphosphatase 1 Is Essential for Inhibition of Notch1 in Breast Cancer.	RPL21 KRT18 RPS13 DNAJC21 MYO1B RPS18 GTF2I THRAP3	5.24e-06	286	115	8	32041737
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	RPL21 PPFIA1 DNAJC21 STMN1 TRIM27 CEP55 CEP350 FAM193A EIF4ENIF1 NOM1 SPEN THRAP3	5.28e-06	724	115	12	36232890
Pubmed	Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma.	RPL21 RPS13 E2F7 RPS18 MCM6 PRPF6 SF3B1 NOM1 THRAP3	5.46e-06	383	115	9	29331416
Pubmed	Deletion of the protein kinase A/protein kinase G target SMTNL1 promotes an exercise-adapted phenotype in vascular smooth muscle.	MYH1 MYH2 MYH4	5.70e-06	11	115	3	18310078
Pubmed	Modulation of contractile protein gene expression in fetal murine crural muscles: emergence of muscle diversity.	MYH1 MYH2 MYH4	5.70e-06	11	115	3	8136524
Pubmed	Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers.	MYH1 MYH2 MYH4	5.70e-06	11	115	3	16024798
Pubmed	Extracellular matrix protein composition dynamically changes during murine forelimb development.	MYH1 MYH2 MYH4	5.70e-06	11	115	3	38303699
Pubmed	The histone code reader Spin1 controls skeletal muscle development.	MYH1 MYH2 MYH4	5.70e-06	11	115	3	29168801
Pubmed	Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.	RPL21 RPS13 RPS18 PRPF6 ZC3H18 THOC2 NKRF GTF2I NOP14 SF3B1 SPEN THRAP3	5.82e-06	731	115	12	29298432
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	MYC EPC2 GTF2I EPC1 TPX2 SPEN	5.83e-06	134	115	6	25452129
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	RPL21 DHX36 POLR1C RPS13 BAZ1B RPS18 MCM6 PRPF6 THOC2 NKRF GTF2I NOP14 SF3B1 POLR1E CDK11B THRAP3	7.26e-06	1318	115	16	30463901
Pubmed	Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins.	PPFIA4 PPFIA2 PPFIA1	7.58e-06	12	115	3	9624153
Pubmed	Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly.	CEP350 FAM193A EIF4ENIF1 CEP131	7.68e-06	38	115	4	36674791
Pubmed	Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.	RPL21 MYH2 KRT18 RPS13 MYO1B RPS18 PRPF6 CEP55 GTF2I RGPD3 THRAP3	7.72e-06	626	115	11	33644029
Pubmed	Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy.	RPL21 RPS13 BAZ1B RPS18 MCM6 PRPF6 NKRF GTF2I NOP14 SF3B1 THRAP3	9.63e-06	641	115	11	36057605
Pubmed	Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles.	MYH1 MYH2 MYH4	9.83e-06	13	115	3	8404542
Pubmed	TAF7L modulates brown adipose tissue formation.	MYH1 MYH4 SCD5	9.83e-06	13	115	3	24876128
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	RALGAPA1 KRT18 PPFIA1 TMEM51 ELP1 MYO1B CEP55 CEP350 NOP14 SSH1 VANGL1 NHS CEP131 GOLGA4	9.96e-06	1049	115	14	27880917
Pubmed	Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension.	CYP4A11 CYP4A22	1.08e-05	2	115	2	15611369
Pubmed	Negative emotionality: monoamine oxidase B gene variants modulate personality traits in healthy humans.	MAOA MAOB	1.08e-05	2	115	2	19657584
Pubmed	Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence.	MAOA MAOB	1.08e-05	2	115	2	21971001
Interaction	CHD4 interactions	RPL21 MYC KRT18 PDPK1 RPS13 BAZ1B RPS18 MCM6 PRPF6 ZC3H18 TRIM27 CXXC1 NKRF RIT1 GTF2I NOP14 SF3B1 NOM1 ZNF644 CDK11B SPEN THRAP3	1.01e-08	938	113	22	int:CHD4
Interaction	DOT1L interactions	RPL21 DHX36 KRT18 POLR1C RPS13 BAZ1B MYO1B RPS18 PRPF6 ZC3H18 THOC2 NKRF GTF2I NOP14 POLR1E UBP1 NOM1 TPX2 UTP20 THRAP3	2.10e-08	807	113	20	int:DOT1L
Interaction	MEN1 interactions	RPL21 MYC DHX36 POLR1C RPS13 BAZ1B MYO1B RPS18 PRPF6 ZC3H18 SYBU THOC2 CXXC1 NKRF GTF2I NOP14 NOM1 ZNF644 TPX2 UTP20 SPEN THRAP3	5.24e-08	1029	113	22	int:MEN1
Interaction	POLR1E interactions	MYC POLR1C PRPF6 CREBBP NKRF RIT1 ARRB1 NOP14 POLR1E NOM1 ZNF644 KDM2B UTP20	8.43e-08	350	113	13	int:POLR1E
Interaction	RPS24 interactions	RPL21 MYC PRUNE2 DHX36 RPS13 RPS18 PRPF6 ZC3H18 NKRF RIT1 NOP14 VANGL1 NOM1 ZNF644 UTP20	2.70e-07	529	113	15	int:RPS24
Interaction	THOC1 interactions	MYC PRPF6 ZC3H18 THOC2 TRIM27 RIT1 SF3B1 TADA2A SPEN THRAP3	2.97e-07	210	113	10	int:THOC1
Interaction	RNF2 interactions	RPL21 MYC EPC2 SYNE1 RPS13 BAZ1B DNAJC21 THOC2 TRIM27 CXXC1 GTF2I NOP14 SF3B1 POLR1E NOM1 EPC1 KDM2B CDK11B THRAP3	3.28e-07	866	113	19	int:RNF2
Interaction	PRC1 interactions	RPL21 MYC BDP1 PPFIA4 SYNE1 POLR1C RPS13 BAZ1B RPS18 MCM6 PRPF6 ZC3H18 RIT1 SF3B1 RGPD3 TPX2 UTP20 KIF13A SPEN THRAP3	4.33e-07	973	113	20	int:PRC1
Interaction	HMGA1 interactions	MYC HEMGN BAZ1B MCM6 ZC3H18 CREBBP RIT1 GTF2I NOP14 ZNF644 TPX2 SPEN THRAP3	6.58e-07	419	113	13	int:HMGA1
Interaction	MFAP1 interactions	MYC BDP1 GRIPAP1 ZC3H18 CEP55 RIT1 SF3B1 POLR1E CEP295 TADA2A CDK11B	8.50e-07	295	113	11	int:MFAP1
Interaction	DHX40 interactions	MYC ZNF536 ZC3H18 TRIM27 NKRF NOP14 NOM1 ZNF644 UTP20 THRAP3	1.41e-06	249	113	10	int:DHX40
Interaction	KIF20A interactions	RPL21 MYC RALGAPA1 SYNE1 POLR1C RPS13 BAZ1B MYO1B RPS18 PRPF6 ZC3H18 THOC2 TRIM27 SF3B1 EIF4ENIF1 FIG4 RGPD3 TPX2 KIF13A THRAP3	1.46e-06	1052	113	20	int:KIF20A
Interaction	RNF113A interactions	RPL21 DHX36 KRT18 RPS13 RPS18 PRPF6 ZC3H18 NKRF RIT1 SF3B1 FAM193A EIF4ENIF1 POLR1E NOM1 UTP20 THRAP3	1.57e-06	692	113	16	int:RNF113A
Interaction	GRWD1 interactions	RPL21 MYC RPS13 E2F7 ELP1 MYO1B RPS18 NKRF SF3B1 POLR1E NOM1 THRAP3	1.99e-06	390	113	12	int:GRWD1
Interaction	FBL interactions	MYC POLR1C RPS13 HEMGN BAZ1B RPS18 ZC3H18 STMN1 NKRF NOP14 EIF4ENIF1 POLR1E NOM1 ZNF644 UTP20	2.86e-06	639	113	15	int:FBL
Interaction	PRPF6 interactions	MYC RPS13 PRPF6 ZC3H18 STMN1 CEP55 RIT1 SF3B1 POLR1E TADA2A THRAP3	3.01e-06	336	113	11	int:PRPF6
Interaction	ACE2 interactions	RPL21 RALGAPA1 GRIPAP1 KRT18 PDPK1 RAB11FIP2 RPS13 BAZ1B MYO1B RPS18 MCM6 PRPF6 CREBBP NKRF ARRB1 GTF2I NOP14 SF3B1 THRAP3 GOLGA4	3.13e-06	1106	113	20	int:ACE2
Interaction	SIRT7 interactions	RPL21 DHX36 ELP1 BAZ1B MYO1B MCM6 PRPF6 ZC3H18 THOC2 NKRF GTF2I NOP14 SF3B1 POLR1E UTP20 SPEN	3.99e-06	744	113	16	int:SIRT7
Interaction	EED interactions	RPL21 MYC DHX36 EPC2 KRT18 RPS13 ELP1 BAZ1B MYO1B RPS18 MCM6 PRPF6 THOC2 NKRF GTF2I NOP14 SF3B1 NOM1 EPC1 KDM2B UTP20 SPEN THRAP3	4.40e-06	1445	113	23	int:EED
Interaction	UTP4 interactions	MYC NKRF RIT1 NOP14 POLR1E UTP20 CEP131 GOLGA4	5.24e-06	170	113	8	int:UTP4
Interaction	PAXBP1 interactions	MYC ZC3H18 THOC2 RIT1 SF3B1 TPX2 SPEN	5.39e-06	121	113	7	int:PAXBP1
Interaction	CDC5L interactions	MYC KRT18 SYNE1 PPFIA2 PPFIA1 ELP1 PRPF6 ZC3H18 THOC2 RIT1 NOP14 SF3B1 TPX2 TADA2A DEPDC7 SPEN GULP1	5.50e-06	855	113	17	int:CDC5L
Interaction	CDK12 interactions	RPL21 MYC BAZ1B ZC3H18 THOC2 RIT1 TPX2 SPEN THRAP3	5.58e-06	228	113	9	int:CDK12
Interaction	RPL31 interactions	RPL21 MYC DHX36 RPS13 RPS18 PRPF6 ZC3H18 NKRF RIT1 NOP14 SF3B1 EIF4ENIF1 POLR1E NOM1 UTP20	6.06e-06	680	113	15	int:RPL31
Interaction	LATS1 interactions	MYC MYH1 MYH2 MYH4 E2F7 MYO1B CREBBP CEP55 CEP350 SF3B1 FAM193A CEP131	6.82e-06	440	113	12	int:LATS1
Interaction	KPNA2 interactions	MYC KRT18 POLR1C MCM6 ZC3H18 CREBBP SF3B1 EIF4ENIF1 POLR1E NPIPB6 TPX2 TADA2A GOLGA4	6.92e-06	519	113	13	int:KPNA2
Interaction	HIF1A interactions	MYC MYH1 MYH2 MYH4 E2F7 ELP1 MYO1B PRPF6 CREBBP CEP350 ARRB1 GTF2I	6.98e-06	441	113	12	int:HIF1A
Interaction	AP2B1 interactions	MYC RALGAPA1 WNK1 CEP55 CEP350 ARRB1 GTF2I FAM193A OSBPL10 CEP131 KIF13A	8.11e-06	373	113	11	int:AP2B1
Interaction	PPARG interactions	MYC ZNF536 POLR1C TRIM27 CREBBP CEP350 GTF2I NOP14 KDM2B TADA2A	9.04e-06	307	113	10	int:PPARG
Interaction	KRR1 interactions	MYC DHX36 RPS13 BAZ1B RPS18 ZC3H18 NKRF NOP14 SF3B1 POLR1E NOM1	9.43e-06	379	113	11	int:KRR1
Interaction	CTCF interactions	RPL21 MYC KRT18 RPS13 DNAJC21 RPS18 ZC3H18 NKRF POLR1E NOM1 THRAP3 GOLGA4	1.09e-05	461	113	12	int:CTCF
Interaction	SRRM2 interactions	MYC RPS13 BAZ1B MCM6 PRPF6 ZC3H18 ARRB1 GTF2I SF3B1 OSBPL10 TADA2A SPEN	1.11e-05	462	113	12	int:SRRM2
Interaction	TNIP1 interactions	RPL21 KRT18 SYNE1 RPS13 DNAJC21 MYO1B RPS18 MCM6 PRPF6 THOC2 NKRF FAM111B GTF2I SF3B1 UBP1 NOM1 TPX2 UTP20 CDK11B THRAP3	1.30e-05	1217	113	20	int:TNIP1
Interaction	RPS19 interactions	RPL21 MYC DHX36 RPS13 BAZ1B RPS18 ZC3H18 NKRF FAM111B RIT1 NOP14 SF3B1 NOM1 THRAP3	1.37e-05	639	113	14	int:RPS19
Interaction	EIF3I interactions	MYC POLR1C RPS13 ZC3H18 RIT1 ARRB1 EIF4ENIF1 TADA2A CDK11B	1.51e-05	258	113	9	int:EIF3I
Interaction	FBXO42 interactions	BDP1 GRIPAP1 RPS13 ELP1 WNK1 FAM111B ZNF644 CEP131 GJA10	1.55e-05	259	113	9	int:FBXO42
Interaction	XRCC6 interactions	MYC PDPK1 BAZ1B RPS18 ZC3H18 STMN1 THOC2 CREBBP ADCY7 RIT1 GTF2I SF3B1 EIF4ENIF1 TPX2 CDK11B SPEN THRAP3	1.60e-05	928	113	17	int:XRCC6
Interaction	DDX23 interactions	RPL21 MYC SYNE1 PRPF6 ZC3H18 THOC2 NKRF RIT1 NOP14 SF3B1 UTP20 THRAP3	1.63e-05	480	113	12	int:DDX23
Interaction	KLF8 interactions	EPC2 RPS13 BAZ1B CREBBP GTF2I NOP14 ZNF644 EPC1 KDM2B SPEN	1.65e-05	329	113	10	int:KLF8
Interaction	KIF23 interactions	RPL21 MYC DHX36 POLR1C RPS13 MYO1B RPS18 PRPF6 ZC3H18 THOC2 TRIM27 NKRF CEP55 RIT1 NOP14 SF3B1 FIG4 THRAP3	1.67e-05	1031	113	18	int:KIF23
Interaction	HNRNPU interactions	RPL21 MYC DHX36 KRT18 ARMC12 RPS13 ELP1 BAZ1B RPS18 MCM6 ZC3H18 NKRF RIT1 ARRB1 SF3B1 OTUD6B TPX2 THRAP3	1.76e-05	1035	113	18	int:HNRNPU
Interaction	RPS10 interactions	RPL21 MYC DHX36 PPFIA1 RPS13 BAZ1B RPS18 ZC3H18 NKRF FAM111B RIT1 SF3B1 NOM1	1.77e-05	567	113	13	int:RPS10
Interaction	TRNT1 interactions	MYC PPFIA2 PPFIA1 RIT1 GOLGA4	1.83e-05	58	113	5	int:TRNT1
Interaction	RPS2 interactions	RPL21 MYC DHX36 GRIPAP1 RPS13 BAZ1B RPS18 ZC3H18 NKRF FAM111B RIT1 ARRB1 SF3B1 NOM1	1.87e-05	657	113	14	int:RPS2
Interaction	NOP56 interactions	RPL21 MYC RPS13 PRPF6 ZC3H18 NKRF RIT1 NOP14 POLR1E NOM1 UTP20 CEP295 CDK11B	1.87e-05	570	113	13	int:NOP56
Interaction	POLR1G interactions	MYC POLR1C PRPF6 ZC3H18 NKRF RIT1 ARRB1 NOP14 POLR1E ZNF644 KDM2B UTP20	1.96e-05	489	113	12	int:POLR1G
Interaction	EIF3B interactions	RPL21 MYC RPS13 RPS18 ZC3H18 RIT1 CEP350 EIF4ENIF1 TADA2A CDK11B	2.02e-05	337	113	10	int:EIF3B
Interaction	ELP3 interactions	MYC ELP1 FAM219B RIT1 NOP14 POLR1E EPC1	2.10e-05	149	113	7	int:ELP3
Interaction	RCOR1 interactions	MYC ZNF536 GRIPAP1 PPFIA1 RPS18 GTF2I FAM193A EIF4ENIF1 KDM2B CEP131 TADA2A SPEN	2.16e-05	494	113	12	int:RCOR1
Interaction	ANKRD36B interactions	ANKRD36C ANKRD36B VANGL1 SPEN GULP1	2.17e-05	60	113	5	int:ANKRD36B
Interaction	MYCN interactions	RPL21 MYC DHX36 SYNE1 PPFIA1 RPS13 BAZ1B DNAJC21 MYO1B RPS18 PRPF6 ZC3H18 C1orf167 THOC2 NKRF GTF2I NOP14 SF3B1 POLR1E NOM1 THRAP3	2.25e-05	1373	113	21	int:MYCN
Interaction	CSNK2A1 interactions	RPL21 MYC BDP1 POLR1C MYO1B RPS18 ZC3H18 STMN1 ANKRD36C CREBBP NKRF ANKRD36B ARRB1 SF3B1 KDM2B CDK11B THRAP3	2.34e-05	956	113	17	int:CSNK2A1
Interaction	PHF21A interactions	MYC ZNF536 GRIPAP1 PPFIA1 GTF2I FAM193A EIF4ENIF1 KDM2B CEP131 TADA2A	2.35e-05	343	113	10	int:PHF21A
Interaction	EIF4A3 interactions	RPL21 MYC POLR1C PRPF6 ZC3H18 THOC2 TRIM27 RIT1 NOP14 SF3B1 NOM1 THRAP3	2.39e-05	499	113	12	int:EIF4A3
Interaction	APEX1 interactions	MYC RALGAPA1 DHX36 ZNF536 PPFIA1 E2F7 BAZ1B RPS18 THOC2 NKRF ARRB1 NOP14 FAM193A VANGL1 OTUD6B ZNF644 TPX2 CEP131 KIF13A THRAP3	2.43e-05	1271	113	20	int:APEX1
Interaction	BYSL interactions	MYC DHX36 GRIPAP1 POLR1C RPS13 RPS18 ZC3H18 TRIM27 NOP14 EIF4ENIF1	2.54e-05	346	113	10	int:BYSL
Interaction	SRSF6 interactions	MYC DHX36 RPS13 ZC3H18 NKRF RIT1 NOP14 SF3B1 NOM1 CDK11B SPEN THRAP3	2.58e-05	503	113	12	int:SRSF6
Interaction	ABT1 interactions	MYC DHX36 ZC3H18 TRIM27 CXXC1 NKRF NOP14 SF3B1 POLR1E VANGL1 SPEN	2.61e-05	423	113	11	int:ABT1
Interaction	ISG20L2 interactions	MYC ZC3H18 RIT1 NOP14 POLR1E	2.75e-05	63	113	5	int:ISG20L2
Interaction	KPNA1 interactions	MYC EPC2 BAZ1B TRIM27 NKRF SF3B1 POLR1E EPC1 TPX2 UTP20	2.86e-05	351	113	10	int:KPNA1
Interaction	IK interactions	MYC PRPF6 ZC3H18 THOC2 RIT1 CDK11B SPEN THRAP3	2.89e-05	215	113	8	int:IK
Interaction	HECTD1 interactions	RPL21 DHX36 KRT18 ARMC12 POLR1C RPS13 BAZ1B DNAJC21 RPS18 PRPF6 THOC2 NKRF NOP14 POLR1E NOM1 TPX2 UTP20	3.37e-05	984	113	17	int:HECTD1
Interaction	MECOM interactions	MYH1 MYH2 MYH4 BAZ1B MYO1B THOC2 TRIM27 CREBBP GTF2I SF3B1	3.39e-05	358	113	10	int:MECOM
Interaction	YAP1 interactions	RPL21 MYC POLR1C RPS13 BAZ1B MYO1B RPS18 STMN1 THOC2 CREBBP NKRF CEP55 GTF2I TPX2 KDM2B SPEN ARHGAP45 THRAP3	3.71e-05	1095	113	18	int:YAP1
Interaction	KLF15 interactions	EPC2 POLR1C RPS13 CREBBP GTF2I NOP14 ZNF644 EPC1 KDM2B	3.78e-05	290	113	9	int:KLF15
Interaction	KRT8 interactions	MYC MYH1 GRIPAP1 KRT18 ELP1 CEP55 CEP350 FAM193A EIF4ENIF1 CEP131 TADA2A	3.81e-05	441	113	11	int:KRT8
Interaction	USP7 interactions	MYC ZNF536 MAOA SYNE1 PDPK1 PPFIA1 MYO1B MCM6 THOC2 TRIM27 CREBBP NKRF RIT1 GTF2I SF3B1 PLA2G4C NOM1 TPX2 KIF13A THRAP3	3.85e-05	1313	113	20	int:USP7
Interaction	H3C6 interactions	KRT18 E2F7 RPS18 MCM6 GTF2I SF3B1 ZNF644 THRAP3	4.12e-05	226	113	8	int:H3C6
Interaction	FBXW7 interactions	RPL21 MYC POLR1C RPS13 HEMGN ELP1 BAZ1B DNAJC21 MYO1B RPS18 MCM6 PRPF6 ZC3H18 THOC2 SF3B1 NOM1 TADA2A THRAP3 GULP1	4.34e-05	1215	113	19	int:FBXW7
Interaction	MED4 interactions	FAM13C THOC2 WNK1 FAM111B CEP55 RIT1 CEP350 POLR1E CEP131 TADA2A THRAP3	4.58e-05	450	113	11	int:MED4
Interaction	IFI16 interactions	MYC DHX36 SYNE1 POLR1C E2F7 BAZ1B MCM6 NKRF NOP14 SF3B1 POLR1E RGPD3 UTP20 CDK11B	4.64e-05	714	113	14	int:IFI16
Interaction	ELF4 interactions	EPC2 CXXC1 ZNF644 EPC1 KDM2B TADA2A	4.66e-05	115	113	6	int:ELF4
Interaction	RBM22 interactions	MYC PRPF6 ZC3H18 CEP55 RIT1 SF3B1 EIF4ENIF1	4.72e-05	169	113	7	int:RBM22
Interaction	NUP43 interactions	PRPF6 ZC3H18 NKRF RIT1 GTF2I NOP14 EIF4ENIF1 POLR1E ZNF644 EPC1 UTP20 CDK11B SPEN	4.85e-05	625	113	13	int:NUP43
Interaction	FGF11 interactions	MYC POLR1C MYO1B PRPF6 ZC3H18 CXXC1 FAM193A	4.90e-05	170	113	7	int:FGF11
Interaction	CIT interactions	RPL21 DHX36 SYNE1 POLR1C RPS13 BAZ1B MYO1B RPS18 PRPF6 STMN1 THOC2 NKRF RIT1 GTF2I NOP14 SF3B1 RGPD3 TPX2 UTP20 THRAP3 GOLGA4	5.00e-05	1450	113	21	int:CIT
Interaction	ZNF346 interactions	MYC DHX36 RPS13 BAZ1B RPS18 ZC3H18 THOC2 NKRF NOP14 NOM1	5.23e-05	377	113	10	int:ZNF346
Interaction	TUBG1 interactions	RPL21 MYC KRT18 PPFIA1 RPS13 RPS18 GTF2I TPX2 CEP131 CEP295	5.84e-05	382	113	10	int:TUBG1
Interaction	POLR3F interactions	BDP1 POLR1C RIT1 NOP14 POLR1E	6.40e-05	75	113	5	int:POLR3F
Interaction	CEP63 interactions	RALGAPA1 KRT18 SYNE1 CEP55 CEP350 RGPD3 CEP131	6.79e-05	179	113	7	int:CEP63
Interaction	DCPS interactions	RPS13 BAZ1B RPS18 PRPF6 THOC2 RIT1 SF3B1 POLR1E UTP20 THRAP3	7.55e-05	394	113	10	int:DCPS
Interaction	EXOSC7 interactions	RPL21 MYC PRPF6 ZC3H18 RIT1 EIF4ENIF1	8.10e-05	127	113	6	int:EXOSC7
Interaction	ASF1A interactions	MYC BDP1 ZNF536 MCM6 THOC2 ZNF644 TPX2 SPEN	8.13e-05	249	113	8	int:ASF1A
Interaction	STX7 interactions	RALGAPA1 GRIPAP1 PPFIA1 TMEM51 RAB11FIP2 AP4E1 SNX30 GTF2I NOP14 VANGL1 SEMA6A FAM9C GOLGA4	8.30e-05	659	113	13	int:STX7
Interaction	RBM25 interactions	MYC MYO1B ZC3H18 THOC2 RIT1 GTF2I SF3B1 CDK11B SPEN	8.65e-05	323	113	9	int:RBM25
Interaction	FOXR2 interactions	MYC EPC2 POLR1C EPC1	8.90e-05	42	113	4	int:FOXR2
Interaction	CYP4A22 interactions	CYP4A11 CYP4A22	9.31e-05	3	113	2	int:CYP4A22
Interaction	CRX interactions	EPC2 ZNF536 CREBBP ZNF644 EPC1 KDM2B SPEN BAHCC1	9.34e-05	254	113	8	int:CRX
Interaction	EP300 interactions	MYC DHX36 KRT18 POLR1C HEMGN ELP1 BAZ1B MCM6 PRPF6 STMN1 CREBBP CXXC1 NKRF ARRB1 GTF2I NOP14 SF3B1 EPC1 TPX2 THRAP3	9.47e-05	1401	113	20	int:EP300
Interaction	BCLAF1 interactions	MYC MYH7B ZC3H18 THOC2 ARRB1 SF3B1 CDK11B SPEN THRAP3	9.50e-05	327	113	9	int:BCLAF1
Interaction	FGFBP1 interactions	DHX36 RPS13 ZC3H18 NKRF NOP14 SF3B1 VANGL1 NOM1	1.01e-04	257	113	8	int:FGFBP1
Interaction	RBM42 interactions	RPL21 MYC RPS13 RPS18 PRPF6 ZC3H18 NKRF CEP55 THRAP3	1.04e-04	331	113	9	int:RBM42
Interaction	ZC3H18 interactions	RPL21 MYC RPS13 RPS18 PRPF6 ZC3H18 THOC2 NKRF GTF2I NOP14 SF3B1 VANGL1 OSBPL10 SPEN THRAP3	1.14e-04	877	113	15	int:ZC3H18
Interaction	EIF3C interactions	MYC BDP1 PRPF6 ZC3H18 RIT1 EIF4ENIF1 TADA2A CDK11B	1.19e-04	263	113	8	int:EIF3C
Interaction	TPM1 interactions	MYC MYH1 MYH2 MYH4 MYH7B THOC2 SF3B1 FAM9C	1.19e-04	263	113	8	int:TPM1
Interaction	VPS33B interactions	MYC DHX36 GRIPAP1 PPFIA1 CEP350 EIF4ENIF1 CEP131	1.32e-04	199	113	7	int:VPS33B
Interaction	NPIPB6 interactions	TRIM27 RIT1 NPIPB6	1.32e-04	18	113	3	int:NPIPB6
Interaction	SFN interactions	MYC RALGAPA1 KRT18 PDPK1 PPFIA1 RPS13 RPS18 ZC3H18 WNK1 CEP350 NHS CEP131 KIF13A	1.35e-04	692	113	13	int:SFN
Interaction	KLF16 interactions	MYC RPS13 BAZ1B STMN1 GTF2I NOP14 ZNF644 EPC1 TPX2 KDM2B	1.41e-04	425	113	10	int:KLF16
Interaction	SMC5 interactions	MYH1 MYH4 KRT18 BAZ1B RPS18 PRPF6 ZC3H18 THOC2 NKRF GTF2I SF3B1 ZNF644 TPX2 CDK11B SPEN THRAP3	1.44e-04	1000	113	16	int:SMC5
GeneFamily	Myosin heavy chains	MYH1 MYH2 MYH4 MYH7B	2.88e-07	15	71	4	1098
GeneFamily	Phospholipases	PLA2G4C PLCB2 PLCB3	5.97e-04	42	71	3	467
GeneFamily	Zinc fingers CXXC-type	CXXC1 KDM2B	9.78e-04	12	71	2	136
GeneFamily	Phospholipases\|C2 domain containing phospholipases	PLCB2 PLCB3	2.49e-03	19	71	2	832
Coexpression	HUMMERICH_BENIGN_SKIN_TUMOR_DN	MYH1 MYH2 MYH4 SCD5	1.92e-06	21	114	4	MM1102
Coexpression	GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_DN	EPC2 E2F7 STMN1 CREBBP SNX30 KDM2B BAHCC1	2.23e-05	193	114	7	M6903
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	RALGAPA1 BDP1 SYNE1 RPS13 ELP1 BAZ1B RPS18 WNK1 CREBBP ADCY7 CEP350 SF3B1 SSH1 ZNF644 EPC1 PLCB2 SPEN ARHGAP45 THRAP3	2.28e-05	1492	114	19	M40023
Coexpression	GSE6674_CPG_VS_PL2_3_STIM_BCELL_DN	MYC DNAJC21 WNK1 AP4E1 CSRNP1 KCNK5 CEP295	2.80e-05	200	114	7	M6938
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	DHX36 MYO1B WNK1 CREBBP CXXC1 SSH1 ZNF644 THRAP3 GOLGA4 BAHCC1	3.82e-05	467	114	10	M1347
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	BDP1 EPC2 ZNF536 BAZ1B PRPF6 THOC2 CREBBP NHS CDK11B	7.35e-07	186	114	9	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	BDP1 DHX36 BAZ1B DNAJC21 PRPF6 NKRF FAM193A TPX2 CEP295 CDK11B GOLGA4	9.40e-07	311	114	11	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	RALGAPA1 BDP1 DHX36 ZNF536 PPFIA1 BAZ1B DNAJC21 PRPF6 NKRF FAM193A EPC1 TPX2 CEP295 CDK11B GOLGA4	3.85e-05	831	114	15	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	BDP1 DHX36 EPC2 E2F7 BAZ1B DNAJC21 PRPF6 THOC2 NKRF CEP350 FAM193A SYT11 ZNF644 TPX2 UTP20 CEP295 SEMA6A CDK11B THRAP3	3.85e-05	1257	114	19	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500	BDP1 EPC2 ZNF536 HTR1D BAZ1B PRPF6 THOC2 CREBBP UBP1 NHS CDK11B	6.95e-05	492	114	11	Facebase_RNAseq_e10.5_Mandibular Arch_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	BDP1 DNAJC21 PRPF6 TPX2 CEP295 CDK11B GOLGA4	8.06e-05	192	114	7	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	BDP1 DHX36 EPC2 ZNF536 E2F7 BAZ1B DNAJC21 PRPF6 THOC2 NKRF CEP350 FAM193A SYT11 ZNF644 TPX2 UTP20 CEP295 SEMA6A CDK11B THRAP3	9.19e-05	1459	114	20	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst-Confounder_removed-fold2.0_adjp0.05	MYC BDP1 DHX36 EPC2 POLR1C E2F7 MCM6 STMN1 ANKRD36C FAM111B SYT11 POLR1E OTUD6B ZNF644 KDM2B CPXM1 UTP20 CEP131 SEMA6A GULP1	1.11e-04	1479	114	20	PCBC_ratio_MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst_cfr-2X-p05
ToppCell	10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T\|Liver / Manually curated celltypes from each tissue	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2 C18orf63	4.79e-07	182	115	7	81557cdc88777f3bd4e1dd18a760b08fc29122ef
ToppCell	NS-control-d_0-4-Lymphoid-NKT-proliferating\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	RPL21 RPS13 RPS18 STMN1 FAM111B CEP55 TPX2	4.79e-07	182	115	7	f623c47e7806181d09f126066a952162ce49a306
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT18 STMN1 CREBBP CSRNP1 NOP14 SF3B1 GOLGA4	5.75e-07	187	115	7	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Lgr5+_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPL21 MYC KRT18 RPS13 RPS18 MCM6 STMN1	6.86e-07	192	115	7	5155f746ad57122ef735da776c96721005b8dadc
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	SYNE1 E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	8.72e-07	199	115	7	101f78fe6dd1bf9e2e4dd5ad8a970312b3540927
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SYNE1 E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	8.72e-07	199	115	7	e0fcec796afe75e42467ca86355b9fc5aa9ae0a1
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	E2F7 STMN1 FAM111B CEP55 TPX2 CEP295	5.15e-06	169	115	6	b253a4a50c06d36228fcd5d856c57202cbac158f
ToppCell	systemic_lupus_erythematosus-treated-Hematopoietic\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	RPL21 MYC HEMGN RPS18 STMN1 CPXM1	5.33e-06	170	115	6	9a18756e6721980d4b6c37bb52ddfe93ca79c5ab
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RPL21 PCDHB15 RPS13 RPS18 CPXM1 DEPDC7	5.89e-06	173	115	6	5bb11f9ef17213c9b99fdf92b444f5da3b25fc95
ToppCell	PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RALGAPA1 E2F7 STMN1 CEP55 TPX2 TADA2A	6.09e-06	174	115	6	72df66319f6efbd88ecf439013d97409fbf3cb52
ToppCell	PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RALGAPA1 E2F7 STMN1 CEP55 TPX2 TADA2A	6.09e-06	174	115	6	c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235
ToppCell	VE-CD4-proli_CD4\|VE / Condition, Cell_class and T cell subcluster	RPL21 MYC FAM13C PPFIA2 RPS13 RPS18	6.94e-06	178	115	6	f0a0cbf73e03f1b29f0be6598517c8a1da41c8dc
ToppCell	facs-BAT-Fat-24m-Lymphocytic-B_cell\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPL21 MYC RPS13 RPS18 STAP1 ARHGAP45	7.16e-06	179	115	6	932fc2bd62ff024068004825beda1ea493f2d650
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	E2F7 MCM6 STMN1 CEP55 RGPD3 TPX2	7.40e-06	180	115	6	42f48e646fc6e72ad3cce72409ace3a0b64020a2
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MCM6 STMN1 FAM111B CEP55 RGPD3 TPX2	7.63e-06	181	115	6	73b1b59810f60e3e39ca1d5073a5a0d4f5377e6e
ToppCell	systemic_lupus_erythematosus-flare-Hematopoietic-Progen-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	RPL21 MYC HEMGN RPS18 STMN1 OSBPL10	7.63e-06	181	115	6	55fcefa234c8fc707b23248e724756d69827cd18
ToppCell	severe-multiplets\|severe / disease stage, cell group and cell class	SYNE1 E2F7 MCM6 CEP55 NOP14 DEPDC7	8.13e-06	183	115	6	78af8df48f0fe49ac37ccec0ad7b2993883b1148
ToppCell	Bac-SEP-Lymphocyte-T_NK-T_NK_proliferative\|Bac-SEP / Disease, Lineage and Cell Type	E2F7 STMN1 FAM111B CEP55 TPX2 CPXM1	8.38e-06	184	115	6	848d05afd5a2ef61fb8a09c0f5fa2a56fd5c160b
ToppCell	356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	KRT18 E2F7 STMN1 FAM111B CEP55 TPX2	8.92e-06	186	115	6	189b75aa98903f1cb65b624524ba6c30df7e42ff
ToppCell	356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|356C / Donor, Lineage, Cell class and subclass (all cells)	KRT18 E2F7 STMN1 FAM111B CEP55 TPX2	8.92e-06	186	115	6	261891d0b148e285339ae0b9e36136ceabd9b6f5
ToppCell	systemic_lupus_erythematosus-flare-Hematopoietic\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	RPL21 MYC HEMGN RPS18 STMN1 CPXM1	9.48e-06	188	115	6	88b808561ebde997ac8a8bbd1d9bbda49bbb6646
ToppCell	Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative\|Multiple_Sclerosis / Disease, Lineage and Cell Type	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	9.48e-06	188	115	6	6c05797a5d0635d89ffcf4aca52178687129ccb4
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Undetermined\|Myeloid_cells / Location, Cell class and cell subclass	RPL21 MAOB RPS13 MYO1B RPS18 STMN1	9.77e-06	189	115	6	b46adb47768a7b6d801c457d7ba65508edfc36a5
ToppCell	PBMC-Mild-cDC_12\|Mild / Compartment, Disease Groups and Clusters	MCM6 STMN1 FAM111B CEP55 TPX2 UTP20	9.77e-06	189	115	6	946c95d2ecc36b241f58e8c4ad6455fe47c762fa
ToppCell	Int-URO-Lymphocyte-T_NK-T_NK_proliferative\|Int-URO / Disease, Lineage and Cell Type	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.01e-05	190	115	6	005967c540418b85311308072a07c684f4296aef
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	E2F7 MCM6 STMN1 CEP55 VANGL1 TPX2	1.01e-05	190	115	6	c3c65d1f24e0ebdbb9adb617bed299a668f423f5
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.13e-05	194	115	6	f39a471293ecc5c5967b00e772b8f48ebc9affbe
ToppCell	Control-Lymphoid_T/NK-T/NK_proliferative\|Control / Disease group, lineage and cell class	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.13e-05	194	115	6	9bbb124001fba7450f4639f47f9b720a483e7242
ToppCell	Control-Lymphocyte-T_NK-T_NK_proliferative\|Control / Disease, Lineage and Cell Type	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.13e-05	194	115	6	844731b7943d1cfca819b7b89e4e62067bfa0230
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.13e-05	194	115	6	a75ecd0b0a928d4646602f7d16a645f6b3df3af5
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.13e-05	194	115	6	4c1d13d8cb6fb424655c67755ee6dbaf59d6b418
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.13e-05	194	115	6	17744fd6645cf5a447a01a83f07e8d305c2bcd9c
ToppCell	(7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)\|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.13e-05	194	115	6	4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3
ToppCell	moderate-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	E2F7 STMN1 FAM111B CEP350 TPX2 CEP295	1.13e-05	194	115	6	dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCell	control-Lymphocytic-Prol._cells\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.13e-05	194	115	6	4c76508de3291c952386caffda2d559629ba5998
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.13e-05	194	115	6	e14f66f7584909621b776292fbd52808273fd2ee
ToppCell	(7)_Epithelial-J_(AT1-AT2_progenitors)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	KRT18 E2F7 STMN1 FAM111B CEP55 TPX2	1.17e-05	195	115	6	70e6b58c502a2abeb4e36bed179020c675468bd4
ToppCell	(1)_Dll4_loss-of-function\|World / Stress and Cell class	RPL21 RPS13 RPS18 MCM6 STMN1 ARHGAP45	1.17e-05	195	115	6	def4b2350e08a36ffddca71ea80ef611f2d437d9
ToppCell	(1)_Dll4_loss-of-function-(0)_LMPP_(LSK_cells)\|World / Stress and Cell class	RPL21 RPS13 RPS18 MCM6 STMN1 ARHGAP45	1.17e-05	195	115	6	f11cf4b6855a26ff6ea572eebaad2aad6bb2434b
ToppCell	COVID-19-T_cells-Cycling_NK/T_cells\|COVID-19 / group, cell type (main and fine annotations)	HEMGN E2F7 STMN1 FAM111B CEP55 TPX2	1.17e-05	195	115	6	764ed100c28d9bc93ee5ecabc5291c8f184d78da
ToppCell	(4)_B_Hypermutation\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	DEF8 MCM6 STMN1 FAM111B CEP55 TPX2	1.17e-05	195	115	6	54d2acaff6be6b5604591bdbd7d769ac3e74f223
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.20e-05	196	115	6	6d80e23f6a1725a3f5ea7263233c55c2ea56f977
ToppCell	BAL-Control-Myeloid-Myeloid\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.20e-05	196	115	6	bf1d3fae8c01bb3d17c2dafad92b94937c663acd
ToppCell	systemic_lupus_erythematosus-managed-Hematopoietic\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	RPL21 RPS13 HEMGN RPS18 STMN1 CPXM1	1.20e-05	196	115	6	a6fcd4f9a39f8e4ff3076735dd615311104dfd1d
ToppCell	systemic_lupus_erythematosus-managed-Hematopoietic-Progen-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	RPL21 RPS13 HEMGN RPS18 STMN1 CPXM1	1.20e-05	196	115	6	768fce92bcf47734fa6c4a448f1266f34583fb41
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.20e-05	196	115	6	3dd7ed1dfac8d90c8a44f0ae00128bb46d9ef496
ToppCell	control-Lymphocytic-Prol._cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.20e-05	196	115	6	886f7c865b086d6ebb4a1746865c30af6bbed345
ToppCell	(0)_Normal/No_Treatment-(0)_LMPP_(LSK_cells)\|World / Stress and Cell class	RPL21 RPS13 RPS18 STMN1 STAP1 ARHGAP45	1.20e-05	196	115	6	16a23ef14c6e054634873298a320c23ea0444780
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.20e-05	196	115	6	4f649e3bfd21f21682678828673843a7d51c4ff2
ToppCell	BAL-Control-Myeloid-Myeloid\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.20e-05	196	115	6	799c290fb3dfacb666dd0dc3c43ec8a86b697ec7
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.20e-05	196	115	6	0c003a767c3b58605099dab64b9df0d8e5d8bc4b
ToppCell	normal-na-Hematopoietic\|normal / PBMC cell types (v2) per disease, treatment status, and sex	RPL21 RPS13 HEMGN RPS18 STMN1 CPXM1	1.20e-05	196	115	6	c2c1c894706428bad5bfc81e9ae0f921ab1286d3
ToppCell	Control-T/NK_proliferative\|Control / Disease condition and Cell class	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.20e-05	196	115	6	7b7bc25aef49bfd64f79303a92d527bf8188f7a6
ToppCell	ICU-SEP-Lymphocyte-T_NK-T_NK_proliferative\|ICU-SEP / Disease, Lineage and Cell Type	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.24e-05	197	115	6	908e91fa16134b61943aea5e8fc0d6fbac8a8c6e
ToppCell	Control-Myeloid-proliferating_Myeloid_cells\|Control / Disease group,lineage and cell class （2021.01.30）	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.24e-05	197	115	6	ddbe3fe078766bb55f0d7ca1aeb8f9e4aa696d8e
ToppCell	Healthy/Control-T/NK_proliferative\|World / Disease group and Cell class	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.24e-05	197	115	6	4a4d3083938783d6f5b87da02f10e501917da0b4
ToppCell	COVID-19_Severe-T/NK_proliferative\|COVID-19_Severe / Disease condition and Cell class	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.24e-05	197	115	6	718a84e9a8248080f2d964e7c6a3ba183ece9592
ToppCell	10x5'-blood-Lymphocytic_T_CD4/8-lo-Cycling_T\|blood / Manually curated celltypes from each tissue	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.24e-05	197	115	6	1f7c3d193647b66cce6ea202a40758cd10b8bd12
ToppCell	10x5'-blood-Lymphocytic_T_CD4/8-lo\|blood / Manually curated celltypes from each tissue	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.24e-05	197	115	6	acd678586aa0e4375bc8fbcdaa1a796c8dd23885
ToppCell	normal-na-Hematopoietic-Progen-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	RPL21 RPS13 HEMGN RPS18 STMN1 CPXM1	1.24e-05	197	115	6	8c4bda1842ff8bd808517c2aa179ac7596d1923d
ToppCell	systemic_lupus_erythematosus-managed-Hematopoietic-Progen\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	RPL21 RPS13 HEMGN RPS18 STMN1 CPXM1	1.24e-05	197	115	6	4c928a4dde295bf220bcb0b2f30ca4a106b0e511
ToppCell	normal-na-Hematopoietic-Progen\|normal / PBMC cell types (v2) per disease, treatment status, and sex	RPL21 RPS13 HEMGN RPS18 STMN1 CPXM1	1.24e-05	197	115	6	14de3db0b36412e801472a6c1502686ae7be9faa
ToppCell	Healthy_donor-T/NK_proliferative\|Healthy_donor / disease group, cell group and cell class (v2)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.24e-05	197	115	6	b6bbf87e5823fa66b4cad6a7be4f777356887b59
ToppCell	COVID-19_Moderate-T/NK_proliferative\|COVID-19_Moderate / disease group, cell group and cell class	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.27e-05	198	115	6	166c000fb0e19602ffdd8bf2b2f19be2c6df96a6
ToppCell	severe-Lymphocytic-Prol._cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.27e-05	198	115	6	4d8591eabb543ed789f963b507a07c560c76a7c9
ToppCell	COVID-19_Moderate-T/NK_proliferative\|World / disease group, cell group and cell class	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.27e-05	198	115	6	bf0131fbca6032e1aab4aa807f8c1d3be689cb7f
ToppCell	10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	RPL21 MYC RPS13 RPS18 CPXM1 BAHCC1	1.27e-05	198	115	6	a5d66a80bbc1a5aa29d0b763ea9dc3044b8c263d
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SYNE1 MCM6 STMN1 FAM111B CEP55 TPX2	1.27e-05	198	115	6	80b105a7c7d00ea3b5e586831fbb755bd84f9d1a
ToppCell	COVID-19_Severe-T/NK_proliferative\|World / disease group, cell group and cell class	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.27e-05	198	115	6	48045689d0969ff0a14eee7086b8e19b0d6b6065
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SYNE1 MCM6 STMN1 FAM111B CEP55 TPX2	1.27e-05	198	115	6	c73e906d2d12d6eba0e606958be16e63a2292cd0
ToppCell	(1)_T_cell_dividing\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.27e-05	198	115	6	dac3a16e3a070a37f4d0ea37633c23fdc8a9c70a
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-F_2\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.27e-05	198	115	6	bcfe7b6d91f2e2f145cb2660b65fd2a6c1134b86
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.31e-05	199	115	6	11c3d9fe811a4619347f47d2b0e94066e3085625
ToppCell	mLN-T_cell-cycling_gd_T\|T_cell / Region, Cell class and subclass	E2F7 FAM111B CEP55 VANGL1 TPX2 CPXM1	1.31e-05	199	115	6	c81a194f8c2f120c6c4d74857912865a3c2fe1e7
ToppCell	mild_COVID-19-T/NK_proliferative\|World / disease group, cell group and cell class (v2)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.31e-05	199	115	6	d44cc74d7171d96add61dae821daf774b17d4c69
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RALGAPA1 BDP1 SYNE1 ANKRD36C ZNF644 GOLGA4	1.31e-05	199	115	6	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.31e-05	199	115	6	e98ff036d04fc78dffef156bdc0d644532274067
ToppCell	VE-cycling\|VE / Condition, Cell_class and T cell subcluster	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.31e-05	199	115	6	47c47ebc318a0b98841ca2656837bbd068899559
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.31e-05	199	115	6	36c80907b2ec1cbcd1b4e841e6c02a4792591d74
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.31e-05	199	115	6	305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.31e-05	199	115	6	bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c
ToppCell	Caecum-(1)_T_cell-(16)_Tfh\|Caecum / shred on region, Cell_type, and subtype	RPL21 MYC RPS13 HEMGN RPS18 RGPD3	1.31e-05	199	115	6	d07d77ae426dd1164d80d7031f14befa0369d3e5
ToppCell	COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative\|COVID-19_Mild / Disease group, lineage and cell class	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.31e-05	199	115	6	ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.31e-05	199	115	6	7feedb0bf84a3361c8ab5b6674ff64e8ff140c23
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.31e-05	199	115	6	7beb0e07a27fea94674f24eb61c381b0de38ed3e
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.31e-05	199	115	6	123fbf2122aa221d8cbf3aef9361ba0982c07695
ToppCell	COVID-19_Mild-T/NK_proliferative\|COVID-19_Mild / Disease condition and Cell class	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.31e-05	199	115	6	9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7
ToppCell	COVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative\|COVID-19_Severe / Disease group, lineage and cell class	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.31e-05	199	115	6	ddae7fe7633661f15d3c79f5187415ffbfecce67
ToppCell	Healthy_donor-T/NK_proliferative\|World / disease group, cell group and cell class (v2)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.31e-05	199	115	6	1311dfd74b991f48b047a439f04f9bf7dfaa0e7a
ToppCell	Caecum-T_cell-Tfh\|Caecum / Region, Cell class and subclass	RPL21 MYC RPS13 HEMGN RPS18 RGPD3	1.31e-05	199	115	6	fb40f37d842f170ed101dfa3bffdb8f3b2c94f19
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.31e-05	199	115	6	fba48342066aab41a8bcb20db40a6df0158e1cbe
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYH1 E2F7 SCD5 FAM111B CEP55 TPX2	1.31e-05	199	115	6	1d5a3366474c17e3df0ba5cf11b586655529e9bd
ToppCell	VE-cycling-\|VE / Condition, Cell_class and T cell subcluster	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.31e-05	199	115	6	c0a67149a19b65b3069dbc5261d81f658e6e39a2
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.31e-05	199	115	6	6b1304417cf9c44ca70d2bfc2b5acc1a206f25b6
ToppCell	COVID-19_Severe-T/NK_proliferative\|COVID-19_Severe / disease group, cell group and cell class	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.31e-05	199	115	6	af78837f3a7641a5bd98765eef9cb4f86034048c
ToppCell	severe-Lymphocytic-Prol._cells\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.31e-05	199	115	6	b24315952b6ac6c8d2d3a7bd949a5b5392624d4e
ToppCell	mild_COVID-19-T/NK_proliferative\|mild_COVID-19 / disease group, cell group and cell class (v2)	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.31e-05	199	115	6	df2fcaf01b1b48632f84e7355ef21d20853f0664
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-T/NK_proliferative\|COVID-19_Mild / Disease, condition lineage and cell class	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.35e-05	200	115	6	6126a3bbafe2110fba0c1c4493035df4e8193d22
ToppCell	Control-Control-Lymphocyte-T/NK-T/NK_proliferative\|Control / Disease, condition lineage and cell class	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.35e-05	200	115	6	6cf63dd57f6bc0c42e7182322dd24ff9afbe9186
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic-lymphocyte\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	E2F7 MCM6 STMN1 FAM111B CEP55 TPX2	1.35e-05	200	115	6	fcd16d36f67abf154428242b398b71473f281758
Computational	Genes upregulated in subsets of cells of a given type within various tumors	BDP1 BAZ1B CEP350 NOP14 SPEN GOLGA4	7.13e-07	50	69	6	GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN
Drug	4,4'-bisphenol F	HTR1D MAOA MAOB ARRB1 PLCB2 PLCB3	2.15e-06	76	113	6	ctd:C008745
Drug	eye gene	MYH1 MYH2 MYH4 MAOA MAOB CYP4A11 MYH7B MYO1B ADCY7 PLCB2 PLCB3	2.32e-06	369	113	11	CID000004782
Drug	formycin triphosphate	MYH1 MYH2 MYH4 MYH7B MYO1B	5.39e-06	51	113	5	CID000122274
Drug	chlorphentermine	MAOA MAOB PLCB2 PLCB3	7.90e-06	26	113	4	CID000010007
Drug	purealin	MYH1 MYH2 MYH4 MYH7B MYO1B	1.02e-05	58	113	5	CID006419303
Drug	S-(-)-Etomoxir	MYH1 MYH2 MYH4 CYP4A11 MYH7B MYO1B	1.07e-05	100	113	6	CID000060765
Drug	befloxatone	HTR1D MAOA MAOB	1.91e-05	11	113	3	CID000060824
Drug	I 1100	MAOA MAOB	2.44e-05	2	113	2	CID000013067
Drug	trimethyl citrate	MAOA MAOB	2.44e-05	2	113	2	CID000074112
Drug	Pargyline	MAOA MAOB	2.44e-05	2	113	2	DB01626
Drug	tribulin	MAOA MAOB	2.44e-05	2	113	2	ctd:C039776
Drug	Isocarboxazid	MAOA MAOB	2.44e-05	2	113	2	DB01247
Drug	NSC310407	MAOA MAOB	2.44e-05	2	113	2	CID000171344
Drug	C05636	MAOA MAOB	2.44e-05	2	113	2	CID000440736
Drug	4,8-quinolinediol	MAOA MAOB	2.44e-05	2	113	2	CID000440737
Drug	Tranylcypromine	MAOA MAOB	2.44e-05	2	113	2	DB00752
Drug	ethyl 4-hydroxyphenylacetate	MAOA MAOB	2.44e-05	2	113	2	CID000028310
Drug	AC1L2OJZ	MAOA MAOB	2.44e-05	2	113	2	CID000125421
Drug	5HAA	MAOA MAOB	2.44e-05	2	113	2	CID000128291
Drug	methyl indole-3-propionate	MAOA MAOB	2.44e-05	2	113	2	CID000021711
Drug	3-methoxymethyl-7-(4,4,4-trifluorobutoxy)-3,3a,4,5-tetrahydro-1,3-oxazolo(3,4-a)quinolin-1-one	MAOA MAOB	2.44e-05	2	113	2	ctd:C492672
Drug	2-chloroquinoxaline	MAOA MAOB	2.44e-05	2	113	2	CID000238938
Drug	Selegiline	MAOA MAOB	2.44e-05	2	113	2	DB01037
Drug	1 mm PP	MAOA MAOB	2.44e-05	2	113	2	CID000132866
Drug	FNPA	MAOA MAOB SEMA6A	2.53e-05	12	113	3	CID000093121
Drug	2bq7	MYH1 MYH2 MYH4 CYP4A11 MYH7B SEMA6A	3.47e-05	123	113	6	CID006540267
Drug	FMMT	HTR1D MAOA MAOB	4.16e-05	14	113	3	CID006438682
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A	RALGAPA1 BAZ1B SCD5 WNK1 CEP350 UTP20 SPEN	4.47e-05	189	113	7	4304_DN
Drug	Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	TMEM51 AP4E1 ARRB1 GTF2I SF3B1 SSH1 TADA2A	5.28e-05	194	113	7	3867_DN
Drug	fast white	MYH1 MYH2 MYH4 MYH7B	5.57e-05	42	113	4	CID000024008
Drug	esuprone	MAOA MAOB	7.30e-05	3	113	2	CID000065827
Drug	4,6-quinolinediol	MAOA MAOB	7.30e-05	3	113	2	CID000440738
Drug	Monomethylhydrazine	MAOA MAOB	7.30e-05	3	113	2	ctd:D009002
Drug	Zimelidine	MAOA MAOB	7.30e-05	3	113	2	DB04832
Drug	Nialamide	MAOA MAOB	7.30e-05	3	113	2	DB04820
Drug	indoleacetaldehyde	MAOA MAOB	7.30e-05	3	113	2	ctd:C001655
Drug	alpha-methyltryptamine	HTR1D MAOA MAOB	7.69e-05	17	113	3	CID000009287
Drug	clenbuterol	MYH1 MYH2 MYH4 MYH7B MYO1B ADCY7	7.73e-05	142	113	6	CID000002783
Drug	Thimerosal	BDP1 DHX36 MAOA PPFIA4 PRPF6 WNK1 ADCY7 FAM111B CEP350 SF3B1 VANGL1 OTUD6B EPC1 SEMA6A SPEN THRAP3 GULP1	8.65e-05	1199	113	17	ctd:D013849
Drug	heliotrine	MAOA MAOB CYP4A11 CYP4A22	9.46e-05	48	113	4	ctd:C010178
Drug	MDL 11,939	HTR1D MAOA MAOB	1.09e-04	19	113	3	CID000071781
Drug	pargyline	MYH1 HTR1D MAOA MAOB GTF2I	1.23e-04	97	113	5	CID000004688
Drug	U69,593	HTR1D SYNE1 KCNK5 PLCB3	1.30e-04	52	113	4	CID000105104
Drug	AC1L1IZ2	MYH1 MYH2 MYH4 MYH7B MYO1B WNK1 ADCY7 ARRB1	1.40e-04	304	113	8	CID000004795
Drug	N-((5-(3-(1-benzylpiperidin-4-yl)propoxy)-1-methyl-1H-indol-2-yl)methyl)-N-methylprop-2-yn-1-amine	MAOA MAOB	1.46e-04	4	113	2	ctd:C570530
Drug	AC1NOLIN	MAOA MAOB	1.46e-04	4	113	2	CID005090283
Drug	1,4-diphenyl-2-butene	MAOA MAOB	1.46e-04	4	113	2	CID005287453
Drug	spizofurone	MAOA MAOB	1.46e-04	4	113	2	CID000071755
Drug	TMIQ	HTR1D MAOA	1.46e-04	4	113	2	CID000157875
Drug	5-methoxytryptamine	HTR1D MAOA MAOB ADCY7	1.50e-04	54	113	4	CID000001833
Drug	formamidine	MAOA MAOB CYP4A11	1.71e-04	22	113	3	CID000068047
Drug	4-chlorophenylacetic acid	HTR1D MAOA MAOB CYP4A11	1.73e-04	56	113	4	CID000015880
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B SCD5	9.04e-10	13	112	5	DOID:397 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	4.06e-08	10	112	4	DOID:0110454 (implicated_via_orthology)
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	4.06e-08	10	112	4	DOID:0111269 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	4.06e-08	10	112	4	DOID:0080719 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	4.06e-08	10	112	4	DOID:0111602 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	4.06e-08	10	112	4	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	4.06e-08	10	112	4	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	4.06e-08	10	112	4	DOID:0080326 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	4.06e-08	10	112	4	DOID:0111596 (implicated_via_orthology)
Disease	distal myopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	9.51e-08	12	112	4	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	9.51e-08	12	112	4	DOID:2106 (implicated_via_orthology)
Disease	distal arthrogryposis (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	2.60e-07	15	112	4	DOID:0050646 (implicated_via_orthology)
Disease	Diffuse Large B-Cell Lymphoma	MYC PDPK1 CREBBP NOM1 SPEN	2.15e-06	55	112	5	C0079744
Disease	myopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	3.36e-05	48	112	4	DOID:423 (implicated_via_orthology)
Disease	protein C measurement	MYH7B BAZ1B KCNK5	3.48e-05	17	112	3	EFO_0004633
Disease	Malignant neoplasm of breast	MYH1 MAOA KRT18 SYNE1 PDPK1 PCDHB15 ELP1 DNAJC21 STMN1 WNK1 ZNF644 NHS UTP20 SPEN	5.73e-05	1074	112	14	C0006142
Disease	cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	1.57e-04	71	112	4	DOID:0050700 (implicated_via_orthology)
Disease	X-14939 measurement	CYP4A11 CYP4A22	2.12e-04	6	112	2	EFO_0800747
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	2.49e-04	80	112	4	DOID:12930 (implicated_via_orthology)
Disease	Williams Syndrome	BAZ1B GTF2I	3.94e-04	8	112	2	C0175702
Disease	Leukemia, Myelocytic, Acute	MYC CREBBP ADCY7 GTF2I SF3B1	5.29e-04	173	112	5	C0023467
Disease	Liver carcinoma	MYC CYP4A11 STMN1 FAM111B CEP55 CSRNP1 TPX2 CEP131	7.18e-04	507	112	8	C2239176
Disease	autosomal recessive polycystic kidney disease (biomarker_via_orthology)	CYP4A11 CYP4A22	7.68e-04	11	112	2	DOID:0110861 (biomarker_via_orthology)
Disease	Akinetic-Rigid Variant of Huntington Disease	MAOA MAOB	9.19e-04	12	112	2	C0751207
Disease	Juvenile Huntington Disease	MAOA MAOB	9.19e-04	12	112	2	C0751208
Disease	Huntington Disease, Late Onset	MAOA MAOB	9.19e-04	12	112	2	C0393574
Disease	acute myeloid leukemia (implicated_via_orthology)	CREBBP SF3B1	9.19e-04	12	112	2	DOID:9119 (implicated_via_orthology)
Disease	Hepatic Encephalopathy	MAOA MAOB	1.08e-03	13	112	2	C0019151
Disease	Hepatic Coma	MAOA MAOB	1.08e-03	13	112	2	C0019147
Disease	Hereditary Motor and Sensory-Neuropathy Type II	WNK1 FIG4	1.08e-03	13	112	2	C0270914
Disease	Fulminant Hepatic Failure with Cerebral Edema	MAOA MAOB	1.08e-03	13	112	2	C0751197
Disease	Hepatic Stupor	MAOA MAOB	1.08e-03	13	112	2	C0751198
Disease	Hypotension	HTR1D MAOA MAOB	1.09e-03	53	112	3	C0020649
Disease	Williams-Beuren syndrome (implicated_via_orthology)	BAZ1B GTF2I	1.45e-03	15	112	2	DOID:1928 (implicated_via_orthology)
Disease	myelodysplastic syndrome (implicated_via_orthology)	CREBBP SF3B1	1.45e-03	15	112	2	DOID:0050908 (implicated_via_orthology)
Disease	Pheochromocytoma, Extra-Adrenal	MAOA MAOB	1.65e-03	16	112	2	C1257877
Disease	Huntington Disease	MAOA MAOB	1.87e-03	17	112	2	C0020179
Disease	Pheochromocytoma	MAOA MAOB	2.34e-03	19	112	2	C0031511

Protein segments in the cluster

Peptide	Gene	Start	Entry
KRHRVKTRVLRKTLD	SYT11	206	Q9BT88
EEAEHERRVKKRKAR	VANGL1	346	Q8TAA9
IKRREKSKRELLHLT	EPC1	251	Q9H2F5
IKRREKTKRELLHLT	EPC2	251	Q52LR7
AHKLLRAKKAERVEA	BAHCC1	2211	Q9P281
HRARIEIKNKFKREE	BDP1	331	A6H8Y1
KAQSKAHKRRLRILE	C1orf167	1296	Q5SNV9
KLERQAEEERIRKHK	BAZ1B	866	Q9UIG0
RRLEEQKRIHKVPLK	GJA10	136	Q969M2
LQKHRDLAKAVLRRK	FAM219B	71	Q5XKK7
RHRLLEKIRVLEAEK	CEP55	56	Q53EZ4
IQKELEEKRRSRLHK	CREBBP	661	Q92793
EQHVRIRVIKKKKVI	CPXM1	61	Q96SM3
EKIKRKRHLDFLDIL	CYP4A11	281	Q02928
IVKRKHEDLQKALKR	ANKRD36B	981	Q8N2N9
HARVKEKEREHERRK	CDK11B	121	P21127
LQTQVEVKKRRHRLK	DEPDC7	46	Q96QD5
KLAIIERLKEHGDRR	ADCY7	246	P51828
RARHKQRKLEEKARL	FAM193A	871	P78312
EKIHKRNSVRLVIRK	ARRB1	156	P49407
RKFRLKIQEHSIKVL	ARMC12	141	Q5T9G4
KLQHSKEIVRRKAVL	AP4E1	176	Q9UPM8
IVKRKHEDLQKALKR	ANKRD36C	1406	Q5JPF3
RKADRLAKLHKEIRK	MAOA	356	P21397
AHKARKLARLTKEER	MAOB	346	P27338
LINKKRIIEKVIHRL	MCM6	766	Q14566
RRLESKIREHLEKKG	KRT18	106	P05783
TLRRLEHEKRRKEIK	ARHGAP45	371	Q92619
IRKALDRLRKKRHLL	GTPBP6	271	O43824
RHEKLRQRLKEEKLE	CSRNP1	136	Q96S65
IVRLQKDLRMLRKEH	GOLGA4	1946	Q13439
DRRLKKKHQLLEDAR	PPFIA4	806	O75335
LKGVRKHERRVKELA	MYH7B	1886	A7E2Y1
EVHKAIKKRRRRRKE	KCNK5	251	O95279
EAVKGLRKHERRVKE	MYH2	1841	Q9UKX2
HVETKVRAKIRKRKV	NPIPB8	166	E9PQR5
IKRVHKVKANRDVII	LRP5L	186	A4QPB2
HKALDEKVRERLRVA	PPFIA1	171	Q13136
RKLQKKHELLEEARR	PPFIA1	856	Q13136
FSRHKKRLLVVRELK	ELP1	1131	O95163
VKGLRKHERKVKELT	MYH1	1841	P12882
SERDVAKHRLVVLVK	PCDHB15	631	Q9Y5E8
RKRDKRVQAHRKLVE	DNAJC21	211	Q5F1R6
EQERKRLIHKHKREF	NOP14	786	P78316
NRELLRKRKAEVHEK	HEMGN	36	Q9BXL5
KEVKAALKRLIHRTL	OR10A4	296	Q9H209
ERDLRELRKKHQRKA	PLCB3	971	Q01970
ELRKKHQRKAVTLTR	PLCB3	976	Q01970
LRRHRKEKKELQAKI	OTUD6B	16	Q8N6M0
EKAAVERRRLHVLKA	PLA2G4C	16	Q9UP65
ERRRLHVLKALKKLR	PLA2G4C	21	Q9UP65
KHVRILMRRDQVLKL	RGPD3	1391	A6NKT7
IAEEHGKKLLERIRR	CXXC1	421	Q9P0U4
LRRKSDDVHLRKKRK	KDM2B	791	Q8NHM5
YVKRIREKHLAILKE	PCIF1	371	Q9H4Z3
ALIKKVHVTEERGRK	E2F7	346	Q96AV8
NLVKEREKRKHERIL	FIG4	376	Q92562
RIAHLVKELRKELDI	DHX36	941	Q9H2U1
EKIKRKRHLDFLDIL	CYP4A22	281	Q5TCH4
VRDAVRKLKFARHIK	GULP1	46	Q9UBP9
RQHDVKLEKLKERIR	CEP350	276	Q5VT06
HVKIKLADSALERKR	HTR1D	276	P28221
KQKDAVVRLIHLRLK	DEF8	166	Q6ZN54
EDVKRLLKLHKDRFR	C19orf54	96	Q5BKX5
AADIKEHLAAKRKRI	FAM9C	71	Q8IZT9
EHLAAKRKRIEKIAK	FAM9C	76	Q8IZT9
IGRTRKKIVKINELH	FAM111B	191	Q6SJ93
KERIRFVIKKHELLN	GTF2I	426	P78347
LKDLKRQLHLERKRA	GRIPAP1	611	Q4V328
ERKRKADLRHKEALK	CEP295	116	Q9C0D2
HIKARKEALLVEKER	CEP295	146	Q9C0D2
QKLIARHKQEVRRLK	CEP131	716	Q9UPN4
HVETKVRAKIRKRKV	NPIPB6	166	E9PJ23
RLIVSKIAHRSKRKL	C18orf63	626	Q68DL7
SDLRKHRRKIAVVEE	PPFIA2	746	O75334
RRLKKKHELLEEARR	PPFIA2	876	O75334
EIIHRVKKLTCRVKI	KIF13A	861	Q9H1H9
DTLIKFRAHRVVKRK	POLR1E	281	Q9GZS1
IQIHRRARALKKLAK	UTP20	1581	O75691
QLDHLKRVKDLKKRR	TRIM27	146	P14373
KLNRSKRLEKVHVVI	PRUNE2	11	Q8WUY3
RLKLLLKEVSRHIKE	SYNE1	8641	Q8NF91
KERQRRKKIIRDHGL	TADA2A	216	O75478
RKKIIRDHGLINLRK	TADA2A	221	O75478
AVIHRSKRKVLGRKD	NHS	1446	Q6T4R5
KRIEVRVVRRKFKHT	NKRF	276	O15226
IRAKKRVLRKALEHV	PRPF6	386	O94906
EEDLLRKRREQLKHK	MYC	416	P01106
REYAIKILEKRHIIK	PDPK1	106	O15530
VRKHRDVIEKGRKLD	SCD5	161	Q86SK9
VKGLRKHERRVKELT	MYH4	1841	Q9Y623
SRKELRKEKRHLRKA	NOM1	81	Q5C9Z4
EKLKKVVRLARVRDH	POLR1C	291	O15160
DHLRETRADKKRLRK	FAM13C	516	Q8NE31
KRHLEEKQRVEERKR	OSBPL10	721	Q9BXB5
ERLREKDKHIEEVRK	STMN1	121	P16949
LVRKHTKELERLKSV	SSH1	821	Q8WYL5
KILEEDHKGRKRTRR	EIF4ENIF1	241	Q9NRA8
DLRLDIERRKKHKER	THRAP3	716	Q9Y2W1
IERRKKHKERDLKRG	THRAP3	721	Q9Y2W1
RRVHKICQEEKEKRP	THOC2	1146	Q8NI27
KKDALTRLKHLRIVI	RALGAPA1	21	Q6GYQ0
VVEKEGRLKARKHLK	SPEN	951	Q96T58
HALVREIRRKEKEAV	RIT1	176	Q92963
RRKALDKFLKRITDH	SNX30	176	Q5VWJ9
LKTKLKESERRLHER	SYBU	281	Q9NX95
ELLELLKAHKKAIRR	SF3B1	1061	O75533
LIKKAVAVRKHLERN	RPS13	91	P62277
VAVRKHLERNRKDKD	RPS13	96	P62277
HRRKDVAVVQRKEKE	SEMA6A	676	Q9H2E6
IKLHEVLEREKKRRI	STAP1	136	Q9ULZ2
LKVRRIKSEKLHLKD	TMEM51	201	Q9NW97
KGKILAKRINVRIEH	RPL21	81	P46778
VLQELVKHKELLRRK	RAB11FIP2	456	Q7L804
VKHKELLRRKDTHIR	RAB11FIP2	461	Q7L804
KLREDLERLKKIRAH	RPS18	106	P62269
KGVVKLQRRHEKELR	PLCB2	896	Q00722
LRRHVETKGRAKIRK	NPIPB2	126	A6NJ64
GKFKKREELDRHIRI	ZNF536	281	O15090
KDHRRVAVKRVIKES	ZNF644	801	Q9H582
KLVKSIIRVVFHDRR	UBP1	111	Q9NZI7
DLKLELRRLRDKHLK	WNK1	2071	Q9H4A3
RHAKEVLKKATIRKE	ZC3H18	306	Q86VM9
RKTEIIRKRLHKDIP	VWA5B1	321	Q5TIE3
KEELARLRRELVHKA	TPX2	701	Q9ULW0
RELKRLKEEARRKHA	MYO1B	826	O43795